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This report  ai~s to provide a survey of issues relating to health in Community policies u 
a whole.  It is 'the tint of its kind, and is designed to give effect to the commitment of the 
Commission  to  report  on  the  wt.y  health  requirements  fonn  a  constituent  part  of the 
Community's  other policies, in accordance with Article 129 of the E. C.  Treaty. 
The large number  of current CommUDity actions and poli.cies which either directly relate 
to public health or have implications for it are described in the report.  From the description 
of all  these  measures it is  possible to  draw  out  several  major themes  in relation to the 
development of  health-related activities in the Community. 
Health consideratioDI in the fint COIDIIIunlty Treatia 
The first such theme is that health considerations have been present in the policies of the 
Community right from the outset.  One of the underlining objectives of the EBC Treaty is 
that of raising the standard of  living (Article 2) which is clearly of major sipiticance for 
health.  Moreover, the Treaty contains a number of provisions which have formed the basis 
for  important health-related adions. Article 39, for example, on  the Common Agricultural 
policy has led to the harmonisation of health rules for animals, products of  antmal origin, 
and products of  plant origin in order to ensure their free movement in the Community while 
at the same time protecting consumers' health. 
Further relevant provisions are the various Articles governing free  movement.  Article 48 . 
ensures  freedom  of movement  of workers,  Articles  52  to  58  provide  for  the  right  of 
establishment, and Article 59 guarantees the free movement of services. These apply to the 
health sector - to health services,  pati111ta and healdl professionals -just as much as to other 
parts of society.  Under Article 100, health protection provisions relating to foodstuffs and 
pharmaceuticals have been adopted,  and  Article 118 makes specific mention of  health and 
.safety at work. 
Finally, in a particularly striking example of the weight given to health considerations, under 
Article  36 the  basic  principle  of the  free  movement  of goods  is  limited  so that certain 
restrictions  on  imports,  exports  and  goods  in  transit  can  be  imposed  in  order to  protect 
human health and life. 
Health  is  also  explicitly  covered  by  the  Euratom  Treaty .which  in  Chapter  lll sets  out 
provisions for the protection of the  health  of workers and the general  public against thl 
dangers arising from ionising radiation. 
The Siftlle Act 
Not only .has the Community always been concerned with health issues, but that concern hu 
over the years gradually developed and crystallised. This process wu given a great impetus 
by  the  adoption  of the  Single  Act  in  1986,  which  strengthened  the  legal  basis  for 
Community action in relation to health protection. The Act in particular  extended the scope 11 
for  Community  action  on  health  and  safety  of workers (Article  118a) and  in relation  to 
approximation  of laws  (Article  lOOa).  Under  Article  130r  Community  action  on  the 
environment had  to  contribute towards  human  health  and  consumer protection.  Also by 
virtue of Article lOOa,  proposals for measures establishing the internal m(lrket were to have 
as  a base a high level of health protection. 
On the foundations laid by this Act much work has been carried out to improve consumers' 
health protection, for example through the adoption of directives on safety of toys (1988) 
and general product safety (1992).  Similarly, using Article 118a as a basis, the framework 
directive 89/391/E.EC covering the principal aspects of health and safety at work and a vast 
body of specific directives on particular aspects of occupational safety and health has been 
elaborated. 
The Treaty on European Union 
The Treaty on European Union, which came into force on 1 November 1993, continued the 
gradual evolution of Community involvement in health.  The Treaty built upon the existing 
Community competences in the health field in two important ways.  First, it introduced or 
strengthened  provision in  a  number of policy  areas  with  an  impact on  health.  Relevant 
provisions include  : 
- Article 75(c) on measures to improve transport safety, 
- Article 129a, on the contribution to the attainment of a high level of consumer protection, 
- Articles 126 and  127 on the development of quality education and vocational training, 
- Title VI on cooperation in the fields of Justice and Home Affairs. 
Second,  in  Articles  3(o)  and  Article  129  the  Treaty  introduced  a  specific  Community 
competence  on  public  health.  The  Community  was  given  the  objective  of making  a 
contribution to the attainment of  a high level of  health protection.  This opened up for the 
first time the prospect of developing a fully consistent and planned Community approach to 
public health which would integrate t~e various strands of action being taken in this area 
into a coherent overall strategy with established priorities and aims. 
At the same time, by providing a clear framework for Community actions in this field and 
by  placing  a firm  emphasis  on  prevention  of disease  as  the  core  of Community  work, 
Article 129 can be seen as helping to define and circumscribe the scope  of future action. 
Previously the public health actions taken,  based on specific Council requests, differed in 
their  scope  and  objectives.  With  the  new  Treaty  provisions  it will  be much  easier than 
hitherto to establish a clear direction and focus for the Community's  public health actions. 
One of the principal provisions of Article  129  is that health protection requirements shall 
form a constituent part of  the Community's other policies. This provision has consequences 
for  the  formulation  of Community  policies  in  other  areas  and  for  the  measures  and 
instruments  proposed by  the  Commission to  give effect to  these  policies.  It requires the 
Commission  to  check  that  proposals  for  policies,  and  implementing  measures  and 
instruments, do not have an adverse impact on health, or create conditions which undermine 
the  promotion  of health.  It  will  in  addition  be  possible  to  promote  health  protection 
requirements in the context of other policies, on the basis of this Article 129.  Article 129 
in its paragraph 3, also provides for the cooperation with third countries and the competent 
organizations in the sphere of public health. l1l 
The Commission's communication on  public health 
In November 1993 the Commission adopted a Communication on the framework for action 
in the field of  public healtlf
1>  setting out its strategy for implementing the .Treaty provisions. 
At  the  same time,  in  order to  ensure that health  considerations were  properly taken  into 
account  in  other  Community  policies,  the  Commission  also  decided  on  the  following 
arrangements  :.  · 
-the reinforcement of interservice consultation prior to Commission decisions  whenever a 
decision might  have implications for public health; 
- the  setting  up  of an  Inter-Service  Group  on  Health  to  ensure  mutual  exchange  of 
information and internal coordination with regard to health and health protection aspects of 
policies and legislative proposals; and finally, 
- the  production of an  annual  report  in which  there would  be  information  on  the  health 
implications of other policies. 
The report on health protection requirements in Community policies 
This Commission report is the first annual report on the health implications of other policies. 
As well  as being a response to the obligations of·the Treaty,  it also provides a method of 
fulfilling the  wishes expressed by the Council,  the European Parliament, and  the Economic 
and Social Committee, for an overview of health-related Community action. The CouncU<2> 
and the European Parliamene> <•>  have in recent months both underlined  the need to ensure 
an effective intersectoral cooperation in health-related areas and a better integration of  health 
protection aspects in Community and Member States' policies.  Similarly, in July  1994, the 
European and Social Committee recommended<'> that a suitable link be made between health 
policy and the socio-economic dimension of the Community's work. 
Health protection requirements are dealt with in this report within the context of the whole 
range of health matters in which the Community is involved. This is both in order to provide 
a broad overview of such work and a proper perspective in which to view health protection 
activities, and also to demonstrate that in many areas Community work on health goes well 
beyond the parameters for public health activities established by Article 129. For example, 
activities with regard to research, training of professionals, pharmaceuticals, telematics and 
social  security all  have an impact on the provision and organisation of health care. 
The report illustrates how the Community has tackled health-related issues  in different ways 
and  in  different  contexts.  A wide variety  of areas of Community  competence  have been 
involved,  such as the internal  market, competition policy,  research,  education,  energy and 
agriculture policy.  For each area of Community policy with an impact on health the health 
aspects  are  analysed  and  the  specific  actions  which  implement  the  health  protection 
requirement in the Treaty are summarised. 
(I) 
(2) 
(3) 
(4) 
(S) 
COM(93)559 fmal of24 November 1993 
Council R.etolution of 2 JW1e  1994 on the framework for Community action in the field of public health, 
OJ c 165, 17.6.1994, p.l 
Resolution  of  the European Parliament of 19  November  1993  on  public  health  policy  after Maastricht, 
OJ N• C 329, 6.12.1993, p.  375 
Resolution of the European Parliament of 6 May 1994 on the submission of  the European Parliament to the 
World Health Orpnilation'a European Conference on  environment and  health  OJ C 205  of 25.07.1994, 
p.  521. 
Opinion  on  the  Commission  Communication  on  the  framework  for  action  in  the  field  of public  health, 
OJ C 388 of 31  ~ember  1994, p.3 lV 
In this way the report shows how deeply embedded health considerations are throughout the 
spectrum of  the Community's work and  reveals the close and intricate links between health 
activities and those in other areas. 
Interaction between public health and other activities 
In the first  pla~e it can clearly be seen  that other Community policies 'can have considerable 
impact on  public health.  This is the case for  policies which  are not primarily directed at 
health protection, but rather at very different areas such as transport and energy, which can 
nonetheless have an  important impact on  health.  Other policies may  have a  more direct 
influence such as the measures leading to improvements in the quality of the environment 
which thus may benefit citizen's health.  On the other hand,  certain Community actions in 
agriculture,  say,  may have both a positive influence and  a less positive influence. Actions 
to  promote fresh  fruit and vegetables are  particularly important,  whereas support for the 
production, import and promotion of tobacco, or for the preferential promotion of full  fat 
milk without the appropriate warnings of total fat intake, might  have a negative  effect on 
health. 
Secondly, the report demonstrates that other Community policies which have an impact on 
health may themselves need to be complemented by  public health measures to ensure that 
their consequences for health  are as  beneficial and effective as possible. 
One  example  is the  area  of pharmaceuticals  where  the  Community  has  achieved  major 
accomplishment in the area of public health, while taking account of industry's interests. The 
criteria and procedures for the authorisation of medicines have been extensively harmonised 
together with other important aspects of pharmaceutical legislation such as the rational use 
of medicines.  Equally,  much  scientific  work  has  been  supported  within  the  large-scale 
Community  research  and  development  framework  programme.  With  the  new  Treaty 
competence the  existing  achievements  can  be  complemented by  activities  relating to the 
public health dimension of  pharmaceuticals- their role within the health system, their rational 
use by health professionals, understanding by the public, and so on. 
Similarly,  existing  Community  pharmaceutical  legislation  does  not  cover  labile  blood 
components  and  the relevant  national  legislation  and  rules  vary.  In  this  field,  therefore, 
additional  Community  public  health  action  is  desirable  to  ensure  the  safety  and  free 
movement of blood within the Community, and to improve the confidence of the citizens in 
the safety of the blood transfusion chain. 
Thirdly,  the report demonstrates clearly that the converse is also true,  namely that public 
health actions themselves need to be accompanied by measures in other areas if they are to 
be fully effective. The issue of drug dependence is a notable example of this.  Public health 
actions  aimed  at  reducing  demand  for  drugs  and  minimising  dependence  must  be 
complemented by measures to tackle the supply of drugs and  the various judicial, police and 
external  relations questions that arise.  The  Global  Action Plan for the European Union to 
combat drugs contains all  these elements. 
HIV/AIDS  provides  another  example.  As  a global  and  multi-faceted  phenomenon AIDS 
requires a response spanning a number of areas.  The Community's public health actions, 
which cover the areas of prevention, education and support are therefore complemented both 
by a large-scale research commitment within the BIOMED programme and by a programme 
of  AIDS-related developmental  assistance. .• 
v 
Finally, the report illustrates how Community policies can contribute to improving human . 
-c}JuJtllz wru. .-taining  a balance between economic and social interests. The  varied actions 
taken by the Community have helped to improve health not least by  increasing citizen's 
awareness and understanding of their health and its determinants which .has had a positive 
impact on lifestyles. For example, the "Europe Against Cancer" programmeC
6> has contributed 
towards beneficial changes in patterns of nutrition,  such as an  increase in consumption of 
fresh  fruit  anq  vegetables and  a  reduced  intake of saturated  fat  in· Member  States.  The 
-promotion of  the consumption of olive oil and of  fish products in the context of Community 
agricultural and fisheries policies is a further example of such an action. 
A contribution to transparency 
The growing attention given by the media to an enormous number of health topics ranging 
from AIDS and cancer to the quality of medical care, the effects of environmental pollution 
.  and  stress  at work is a  reflection of people's  deep  interest in  and  concern  about health 
matters. By._providing information on the impact of Community action and policies on the 
health  of the  population  of the  Community,  this  report  is  intended  to  contribute  to 
reinforcing the transparency and openness of the Union, thus increasing its acceptance by 
its citizens and bringing the Community Institutions closer to them.  , 
(6)  Council Decision of 17 May 1990, OJ L 137 of 30.5.1990 I  ·I. PREAMBLE  I 
On  24  November  1993,  the  Commission  approved  a Commission  Communication  on  the 
framework for action in the field offJflblic Jteahh<'>  in order to meet the objectives introduced 
by Articles 3(o) and  129 of the EC Treaty. 
In order to respond to the obligation in Article  129 that health protection requirements shall 
form a constituent part of the Community's other policies, the Commission decided to submit 
an annual  report on related aspects in Community policies,  programmes and actions. 
This report is the first of such annual reports, covering the question of the health aspects of 
other policies as described by the various Commission departments involved. 
The structure followed  in this report follows the  lines of the Commission's annual  General 
Report on the Activities of the European Communities. 
Future reports on health protection, starting with that for  1995, will report on new initiatives 
in the different areas of Community policy involved, review the progress made, and consider 
the possibilities and issues that lie ahead. 
(7)  COM(93)339 final 
1 D.  HEALTH PROTECTION ASPECTS OF THE SINGLE MARKET AND THE 
COMMUNITY ECONOMIC AND SOCIAL AREA 
2.1  Statistics 
I 
1.  Reliable and comparable statistical data are an essential tool  for the European Union in 
defining, implementing, monitoring and evaluating its policies. It is Eurostat's mandate 
to provide official statistics to ensure a common statistical language at the level of the 
EU and to disseminate the results to interested parties in  and outside the Commission 
services. 
2.  By  its Decision 93/464/EEC of 22  July  1993(1>,  the Council  agreed on  the framework 
programme for priority actions in the field of statistical information 1993-1997; sectoral 
programmes for social policy, including statistics on health and safety,  are an  essential 
element in this framework  programme.  Close involvement of the National  Statistical 
Institutes  in  the  execution  of this  programme  is  assured  through  the  Statistical 
Programme Committee, established by Decision 89/382/EEC, Euratom<
2>. 
(I) 
(2) 
Eurostat's  activities  in  the  context  of this  new  programme  and  previous  statistical 
programmes have led inter alia to the collection, analysis and dissemination of statistics 
on  health and safety, its determinants and consequences in the following fields : 
demography (e.g. fertility, mortality, population projections, causes of death); 
transport (e.g. road accidents and railway casualties); 
working conditions (accidents at work (ESAW) and occupational diseases (EODS)); 
statistics on persons with IDH (impairments, disabilities and handicaps); 
poverty and social exclusion; 
health resources statistics (e.g.  health personnel and hospital beds); 
family budget surveys (e.g. household consumption expenditure on medical care and 
health, on food,  alcohol and tobacco); 
labour  market characteristics : Labour Force Survey (e.g.  numbers of days/hours 
lost at work due to sickness); 
education and training (e.g.  enrolment for  and  graduates in  "medical  science and 
health-related studies"); 
environment (e.g.  air emissions, waste,  inland waters,  noise) 
social  protection  : ESSPROS (social  security benefits for  "sickness",  "maternity" 
and "invalidity/disability"); 
national accounts : ESA (e.g.  general government expenditure on  health affairs). 
home and leisure accidents : EHLASS (assistance on  methodological aspects). 
In addition, data on health and safety will become available via the time use survey (in 
preparation).  Statistics on  a variety  of socio-economic items  such  as  income,  labour, 
OJ No L 219, 28.8.1993, p.  1 
OJ No L 181, 28.6.1989, p.  47 
2 . 
·  housing,  health,  social  retatiola ad socilbitity  will  be  obtained  via  the  European 
ComrmmitJ-~ci-~  ~fft.wnl ..  Will.be M'llillble iJY lti~S)-1 f  J i  A j-;  II I 
3.  In 1994, Eurostatswted to dewlap a  new framework for health statistics at CommunitY 
16Vel, including lfUisti£& oa heakh-llltUI. on health determiaants- and on health services 
and health resources. Puture activities Oft health statiltics wiH continue to be developed 
in close coqaboration with ird!*uadeaal orpnisatiORJ active in this'field (WHO, OBCD). 
In 1ine with the. above lftflltiaud framewcxk prosramme 1993-1997 and in cooperation. 
with intematioul orpnilltim&  ~dive  in tis field (WHO,  OECD) future actiVities on 
health and safety statiltict win cover inlu  alia a more-detailed aulysis of mortality and 
morbidity by caue. EurOitat is _.  ilmived in the prwpntory work for· Commiuion 
proposals conceming a programme oa "Haath data and indicators" in the context of  its 
framework for· action in the fteld of  public health. 
l.l lgtcrnllllltket 
2.2.1.1  Dangerous  substanees,  -pharmaceutical  products,  foodstuffs; 
-~.:-t devi  ~~  ces 
4.  • Du•IM•D 1 1C11 llfl PT'ati?• 
(3) 
{4} 
(!} 
·(6) 
(7) 
Health  implication~ or COftlideratieas are fully  taken illto ICCOWlt when EC ligialation 
in  this  field  is  drafted  aad  adoptal.  'I1is  position  varies  accordina  to the  aceivity 
involved. Protection- of  healtll can he inclucled in the "eaential requirements" that thould 
be fulfilled by processes or  by productl before goina on the lftll'ket'>. Moreover, specific 
pieces· of legislation  CODtaiJl  provbiona  regarding  the  marketing  or  use  of certain· 
dangermls sub*'D& anti  prepa~atioDJ<
4), 1be clusificatiOD, packaging and labeHiq of 
danaerout preparatio~  or th  maer'actaring and the placing on the- market of llii'COtic 
drugs and psychotropic S1Jbat:ancesC4. 
The legislation Oil dangerous. subttaRael aacl preparations, which 1p1111 a period of  nearly 
30 years, is very e:xteftlive.  It  prcMDa-far the clusification, pacbgina and labellina of 
many thouaands ofdlaprous aubltllal aad for about a million dangerous preparatiODI .. 
It also provides. for limitations on tfte: mllbtina and use of  forty aubltlncea and sroupa 
of substaaces where risks ClftDOt a  cantfdled by simpler means.  This acids up to an 
exteaiive packap of  health protdon  .measures. 
In  the lesislative fietcl,- the znajor acbie'u •nent of 1994 wu the final  adoption by the 
Council .  and  Bumpean Parliament of three Directives.  These  related to  protection of 
consumers from  the  dangem to health  poled by  nickel-notably in jewellery(7).  to the 
See Couummication oa·Conmuetiea of  Felmluy-of  18 1994 (OJ No C 62) or  COM(93)646 on cableway 
installations to cany ,..,.... 
See Council DirectiYe- 761769tf!JJ£ of 21nm (OJ No L 262 of 27.6.1-976) 
See Counc:il Di~lamtiBEC  ot.,._(OJ  No L 187 of 16.7.1911) 
See Couaeil Dmc!ivc 9lf18M!BC of ff/11192 (01 No L 370, 19.12.1992) 
OJ L  1  R  of 22.07,94' p.l 
3 ~prott.Gti011. o£,tiQ11Sumers  (especially children) from  the dangers associated with use of 
flammable gases in certain aerosol products <•>  and to the protection of consumers from 
creosote, chlorinated solvents and substances classified as cancerogenic, mutagenic and 
toxic to reproduction<
9>. 
An important new development is the desire of certain Member States to apply their. own 
national rules in place of Community legislation.  Thus the Commission decided to ail ow 
Germany  tp keep  its national  rules on  Pentachlorophenol  (PCP) in place of the PCP 
Directive  and  to  take  account,  thereby,  of a  special  danger to  health  posed  by  this 
substance  to  German  consumers<•o>.  A  further  three  applications  to  derogate  from 
Community Directives on dangerous substances for reasons of  health protection are under 
active examination.  There is every sign that differences between Member States will be 
further  aggravated  by  the  recent  enlargement  of the  Union.  The  services  of the 
Commission will try to build a better consensus among Member States by introducing 
a more planned approach to legislation on dangerous substances and preparations and by  . 
promoting scientific evaluation at all  stages in the legislative process. 
5.  • Pharmaceutical products 
EC pharmaceutical legislation, since the first directive in 1965, has constantly aimed at 
the  promotion and protection of public health.  By  requiring strict· quality,  safety and 
efficacy  criteria to be  complied with before  a  medicinal  product can  be authorised, 
patients have been given protection which did not previously exist. The gradual extension 
of this  legislation  to all  types  of medicinal  products  (e.g.  vaccines,  blood  products, 
radiopharmaceuticals, etc.) and the constant adaptation of  testing requirements to progress 
in  scientific  and  technical  knowledge  have  given  the  Community  a  comprehensive 
legislative  framework  for  marketing  authorisation  of medicinal  products  and  other 
important issues such as the rational use of medicines  .. 
6.  The  harmonization  of pharmaceutical  legislation  was  completed  in  1993,  but  the 
decisions on the authorisation of individual medicinal products had also to be addressed. 
The Council of the European Union adopted in June and July  1993 a regulation<11>  and 
3 directives <•
2
> concerning the creation of  two new Community authorisation procedures 
for  human  and  veterinary  medicines and  the  establishment of a European Medicines 
Evaluation Agency (EMEA). 
(8) 
Under the new system for marketing authorization in the European Union,  innovatory 
medicinal products will be authorised centrally via the EMEA, and marketed in all  the 
Member States of the European Union. Conventional medicinal products will be subject 
to a decentralised procedure mutually recognised by the Member States. 
The  supervision  of medicinal  products  circulating in or exported from  the European 
Union (inspections and pharmacovigilance) will be coordinated by  the EMEA in close 
liaison with the Member States. 
This will give all patients throughout the Community earlier and simultaneous access to 
important innovative medicinal  products,  such  as  anti-cancer agents,  products for the 
OJ L 331  of  21.12.94 p.  7 
<
9
>  OJ L 365 of  31.12.94 p.  1 
(lO)  OJ L 316 of 09.12.94 p. 43 
(Ill  Regulation (EEC) n· 2309/93 of 22.07.93, 0. J.  n· L 214, 24.08.93, p.  1 
(l
2
l  Directives 93139/EEC, 93/40/EEC and  93/41/EEC of 14.06.93, 0. J.  d"  L  214, 24.08.93, p.  22 to 40 
4 treatment of AIDS,  new vacciftl, etC.  Plwmaceuticals will  be marketed in the whole 
European Union under identical conditiont of use and pUblic conficlellce will no longer 
.be undermined by national differences in safety evaluation of the same drug. 
7.  In the Communication from the Commillion on the outlines of an industrial policy for 
the  pharmaceutical  sector in  the European  CommunityUl),  it is  made  clear  that  it is 
essential  ~o  ensure  that  the  CommUDity's  pharmaceutical  ·industry  retains  its. 
competitiveness. while .takiag into ac:caunt the specificity of  this industry: the vital role 
played by  medicinal  products in  public health,  and  the cost of such  products.  which 
represents  a  larp  proportion  of social  security  budgets.  In  this  Connection  the 
Commission's  communication  includes  a  proposal  to  inteftlify  the  dialogue  already 
initiated  in  the  plwmaceutical  field with  the  Member  States,  for  example  through 
measures aimed  at health  profeuicmals and consumers  to promote the rational  use of 
medicinal  products. 
8.  In 1989,  the  Council  decicled  that  medicinal  products derived  from  human  blood  or 
pluma should be subject to the strict criteria laid down for other medicinal products, in 
order to ensure their quality and their safety from viral cOntamination<
14>.  This topic has 
remained a CO!lStiDt concern of  the hipeat priority; all developments in this area are kept 
under review and the relevant pravilicma lad recommendations are continuously updated 
in the light of scientific ·and techiaic:al prosress. 
9.  In 1992, the Council adopted four directives designed to promote a more rational use of 
medicines in the Eur~  Uni~  namely : 
Directive 92125/BECUSl on the wholesale distribution of medicines, which aims at 
eliminating obstacles to their free circulation through the control of the wholesale 
channel  of distribution  of medicinal  products,  in~uding the  recall  of defective· 
products. 
Directive  921261BEC'
16l  on  the  lepl status  of clauification .for  the  supply  of 
medicinal  products  to  the  patient,  distinguishing  between  those  available  on 
prescription only and those available without a prescription. 
Directive 921271EEC'
1
7) designect to improve patient information, harmonising the 
content of the labelling and the paclcige leaflets of pharmaceuticals. 
Directive  92/28lBEC01>  concerning  the  advertisins of medicinal  products  which 
provides for &ep ..  ate rulea.for advertising to the seneral public, allowed only with 
respect  to  self medication  products,  and  for  advertising  to health  professionals 
which is subject to a more complete system of rules. 
10.  With  regard  to veterinary  medicinal  products,  Regulation (EEC) Nr.  237719f1
1
,  hu a 
major impact on public ,health protection by requiring legally binding maximum residue · 
Ull  COM (93) 718 final or 2.3.1994 
04l  Dircetivc 89/381/EEC, OJ No L 111, 28.6.1919  · 
< 15l  OJ N" L 113, 30.04.1992, P.  1 
(1
6)  OJ N"  ~ 113, 30.04.1992, P.  S 
(l7}  OJ N" L 113, 30.04.91, p. I 
(11)  ·  OJ N" L 113, 30.04.92, p.  13 
< 1
9)  OJ N" L 224 of 18.8.1990 
s limits of veterinary medicinal products in foodstuffs of animal origin to be established 
at Community level. 
11.  .Foodstuffs 
·Community legislation relating to the foodstuffs sector has also consistently i~entified the 
promotion and protection of public health as one of its fundamental objectives. A large 
volume of Community legislation has been produced to ensure the safety of foodstuffs 
sold  in  th~ Community,  notably  as  regards  additives,  flavours,  extraction  solvents, 
contaminants,  materials  in  contact  with  food,  foodstuffs  for  particular  nutritional 
purposes, quick frozen foodstuffs and food hygiene. Certain Community labelling rules 
are also inspired by the need to ensure food safety, notably as regards the "use by" date 
for  perishable foodstuffs.  Moreover,  the  Community  rules  on  the official  control  of 
foodstuffs require Member States to take active measures to verify the safety of the food 
supply.  Further rules are under consideration by the Council for novel foods and food 
ingredients, food irradiation and flavours. 
12.  Virtually all,Community food legislation requires that the Scientific Committee for Food, 
is consulted before the adoption of  provisions which may have an effect on public health. 
In  order to ensure an adequate coverage of all  the disciplines and areas involved, the 
Scientific  Committee  for  Food  has  established  eight  working  parties  covering  food 
additives,  contaminants,  flavours,  exposure  and  intake,  novel  foods  and  novel  food 
processes,  nutrition and dietetic foods,  materials and  articles in  contact with food_ and 
microbiology and food hygiene. 
13.  In  1994,  the Commission launched an  ambitious programme of scientific cooperation 
with the Member States for the further investigation of the scientific aspects of food 
safety, notably in the field of chemical and microbiological contamination of food,  and 
study of dietary intakes. This programme involves the participation of some 80 scientific 
institutes in the Member States dealing with food safety issues. 
14.  In  the legislative 'field, the major achievement of 1994 was the final  adoption by  the 
Council of the three directives relating to food colours<
20
', sweeteners<
2n and additives<
22
' 
other  than  colours  and  sweeteners.  These  directives  establish  positive  lists  of food 
additives, and specify acceptable conditions of  use. Their implementation will ensure that 
food additives are used under safe conditions and do not present a risk for public health. 
In  addition, the Council adopted an amendment to the Directive on extraction solvents, 
while the Commission presented new  proposals in  respect of foodstuffs for  particular 
nutritional purposes and for natural mineral waters. 
(lOl  European Parliament and Council Directive 94/36/EC of 30 June 1994 on colours for use in foodstuffs (OJ 
No L 237, 10.9.1994, p.l3) 
<
21l  European Parliament and Council Directive 94/3SIEC of 30 June 1994 on sweeteners for use in foodstuffs 
(OJ No L 237, 10.9.1994, p.  3) 
<
22l  European Parliament and Council Directive 94/34/EC of 30 June. 1994, amending Directive 89/107/EEC 
on  the  approximation of the  laws  of Member States concerning food  additives authorised for  use  in 
foodstuffs intended for human consumption (OJ No L 237, 10.9.1994, p.  1) 
6 15.  •  Medical devices 
Community Legislation relating to Medical Devices is aimed at providing considerable 
impact on the protection of public health, by  establishing a consiste.nt approach to the 
application of safety requirements in the processes of design, manufacture and marketing 
of such products. 
The legislation is in the form of  three Directives covering the wide range of products and 
technologies experienced in this sector. 
The first, Directive 90/385/EEC relating to the high risk products in the field of "Active 
Implantable Medical Devices", is now fully applicable. Directive 93/42/EEC concerning 
Medical Devices" deals with a large range of products from rubber catheters and blood 
bags to Anaesthesia Machines or X Ray/Imaging Devices. This commenced application 
in January  1995 and will be applied fully by June  1998.  The third and last part of the 
legislative  programme  dealing  with  "In  Vitro  Diagnostic  Medical  Devices"  is  being 
published as a Commission proposal at this time. 
The Directives will ensure that only products):which have been through suitable processes 
to ensure that appropriate essential  requirements~ as  specified, have been followed,  can 
be sold for use in the Community. It also means that the different standards which have 
existed,  in terms  of safety  and  useful  operation,  in  different Member  States:·\vill  be 
replaced  by  a  harmonised  process  of acceptance  which  will  apply  throughout  the 
Community, thus ensuring free movement of effective, safe products. 
The Directives indicate in the preamble the intention to "harmonise in order to guarantee 
the  free  movement of such  devices within the internal  market"  - "for the  safety  and 
health protection of patients, users and, where appropriate, other persons". 
7 2.2.1.2  Case law "free movement of goods" 
16.  Public  health  protection  is  explicitly  referred  to  in  Article  36  of the  EC  Treaty  as 
justification  for  national  measures  prohibited  under  Articles  30  and  34.  It  may  also 
constitute an imperative requirement which Member States may  legitimately pursue,  in 
accordance with the case taw of the Court of Justice (particularly the  "Sandoz",  "Van 
Bennekom': and "German Purity Law" judgments).  According to this case law,  it is the 
responsibility of  the Member States to determine the level to which they intend to protect 
public health.  However, the Court places two limitations on this right: 
a Member  State  may  lay  down  requirements  for  imported  products  which  are 
stricter than those with which they already comply only if  this is justified from the 
scientific point of  view, unless existing uncertainties call for doubt or caution to be 
exercised; 
national  regulations  adopted  to  protect  public  health  must be  appropriate  and  in 
proportion to the objective. 
On 1 June 1994 the Court of  Justice delivered a further judgment referring to Article 30 
and  the protection  of public health:  Case  C-317192  on  the  use-by  date· for  medicinal 
products. 
17.  Health protection aspects have also been covered by judgments of the Court.  Case law 
relating to Article 36 of the EC Treaty is of interest here.  For example: 
a)  Judsment of 27 April  1993,  Commission v.  Greece,  Case C-375/90:  the Court upheld 
Greece's  action  under  Article  36  justified  by  the  presence  of salmonella  in  frozen 
chickens:  if a risk of contamination  may  present a hazard  to  human  health,  it  is  the 
responsibility of the Member State,  in the absence  of harmonisation,  to determine the 
level of protection to be provided, while complying with the requirement to ensure free 
movement of goods. 
b)  Judgment of 22  June  1993,  Gallagher,  Case C-11/92:  if a Directive states  that  public 
health  warnings  to  be  printed  on  cigarette  packets  must  cover  "at  least  4%"  of the 
surface area,  a Member State may require,  as far as domestic production is  concerned, 
that  the  indications  should  cover  "at  least  6%"  since  packets  which  conform  to  the 
Directive  are  ensured  free  movement.  A wording  of the  type  used  by  the  Directive 
establishes only a minimum level of harmonisation. 
c)  "Contact lenses" judgement of 25 May  1993, Case C-271/92: a law prohibiting the sale 
of contact lenses  by  persons  not  qualified  as  opticians  is justified on  the  grounds  of 
protection of public health. The Court refers to the Aragonesa judgment of 25 July  1991 
(Cases  C-1  and  176/9Q)  .. according  to  which  Article  36  allows Member  States,  in  the 
absence  of harmonisation,  to  determine  the  level  of public  health  protection,  while 
respecting the principle of proportionality. 
d)  "Van .der Veldt" judgment of 14 July  1994, salt content of bread,  Case C-17/93: 
8 "As the Court has consistently held,  in the absence of  common or harmonised rules on 
the making and marketing of  bread and other bakery products,  it is for Member States 
to  regulate  all matters relating  to  the  composition,  making and marketing of those 
foodstuffs on their  own territory, provided that they do not thereby discriminate against 
imported products or hinder the importation of  products from other Member States "see 
judgments of 19  February  1981,  Kelderman,  130/80,  ECR 527  and  7 February  1984, 
Jongeneel  ~aas et al.,  237/82, ECR 483)" (ground No 10).  · 
The extension of national regulations on the maximum  salt content of bread and other 
bakery  products  to  products  originating  in  other  Member  States  which  do  not  have 
identical  manufacturing  standards  would  require  those  States  to vary  the  method  of 
manufacture according to the place where the bread or bakery  product in question was 
to be sold and thus impede the movement of products lawfully produced and marketed 
there (ground No 11). 
Although  the  (Belgian)  national  legislation  was  adopted  with  a  view  to  protecting 
consumer health,  the Court holds that this cannot be regarded  as justification for  the 
measure concerned (Article 36 of the EC Treaty). 
The Belgian authorities were limited to expressing the opinion that the levels permitted 
(in other countries) were too high. 
In this connection the Court adds that: 
"General conjecture of  that nature does not prove that increasing salt intake by such an 
amount poses a risk for public health. It is true that,  as the Court has already held (see 
judgment of  6 June 1984, Mel/cunie,  Case 97/83, ECR 2367),  the fact that there is a risk 
to consumers is sufficient to make legislation of  the  kind at issue compatible with the 
requirements of  Article 36.  However,  the risk must be  measured,  not according to  the 
yardstick of  general conjecture,  but on the basis of  relevant scientific research (see,  in 
particular, the judgment of  the Court of  12 March 1987,  Commission v.  Germany, Case 
178184,  ECR 1227)" (ground No 17). 
2.2.2 Mutual recoanition of health  profession diplomas 
18.  Health protection has always been a high priority in the field of mutual  recognition of 
diplomas of the health professions in particular doctors, nurses, midwives, pharmacists, 
dentists and veterinarians.  The Directives concerning these diplomas are based  on  the 
free movement articles of the Treaty, 49, 57 and 66 and aim to facilitate the right of free 
movement of professionals trained in  the Community  in  accordance with  comparable 
standards of training. These standards are co-ordinated, minimum standards. 
However, Advisory Committees on the training of these professionals, set up to support 
the Directives, have the sole task of helping to ensure that the comparable standards are 
maintained at a high level by reviewing them and making recommendations. The work 
of these Committees is aimed at national training and therefore helps to  ensure highly 
trained health professionals which in tum contributes to ensuring health protection in the 
Community. 
9 2.2.3 Data protection 
19.  The common position adopted by the Council (Internal Market) of20 February 1995 on 
the  amended  proposal  for  a  Directive  on  data  protection  takes  full  account  of the 
conclusions of the Council (Health) of May and December 1993  on the implications of 
this proposal for medical research and for social and health services. 
While  preserving  the  Directive's  general  character,  the  Council  has  added  to  the 
derogation introduced for the maximum period for storing data for historical, statistical 
or  scientific  purposes  (Article 6(l)(c)) a  number of clarifications,  notably  in  Article 
6(l)(b) on the compatibility of processing for such purposes with the processing of data 
collected  for  other,  specified  purposes,  or  again  in  Article  11  on  the  provision  of 
information to individuals. The scope of optional derogation from the right of access to 
data processed for such purposes has been extended (Article  13(2)).  The thirty-fourth 
recital expressly mentions scientific research and statistics as being fields  in  which an 
important public interest might justify derogations from the ban on processing sensitive 
data on the basis of Article 8(4). 
Exceptions to the prohibition on the processing of data revealing racial or ethnic origin, 
political opinions or religious or philosophical beliefs or of data concerning health or sex 
life,  have been added in order to cover justified needs,  essentially  in  the  medical  and 
employment fields,  subject to suitable safeguards. 
Derogations for  reasons of important public  interest  and  derogations  from  the  rules 
governing the processing of data relating to offenses,  criminal  convictions or  security 
measures must be notified to the Commission. 
2.2.4 Trans-European networks 
20.  As regards the health-related projects in the context of the telematic interchange of data 
between  administrations in  the Community  (IDA)<
23>,  the  Commission  proposal  for  a 
Council  Decision  on  support  for  IDA  foresees  three  projects  in  the  field  of health, 
namely  CARE  (two  projects  :  early  warning  system  and  pharmacovigilance)  and 
REITOX (European Information Network on Drugs and Drug Addiction which will  be 
at the disposal of the European Monitoring Centre for Drugs and Drug Addiction). The 
two  care  projects  retained  in  IDA  are  spin-offs  of earlier  efforts  on  the  European 
Nervous System (ENS-CARE). ENS-CARE was allocated a budget of 4,248 MECUS 
over the period 1991  to 1993; its current situation permits the gradual passage from the 
· pilot  to  exploitation  phase,  with  the  general  architecture  and  infrastructure  for 
communicable diseases,  statistics,  poison control  and  pharmacovigilance deemed very 
satisfactory,  as  is  the  common  technical  approach  developed  for  a  variety  of health 
applications. Under current IDA plans, CARE-Early warning system (CARE-EWS) work 
will  concentrate over the next two years  on  development of the  pilot system  between 
national  administrations,  while  strictly  adhering  to  the  general  system  architecture 
foreseen for IDA. 
<
23>  OJ No C  lOS,  16.4.1993 
10 21.  Generally  speaking,  Community  competition  policy  does not play  a major role in  the 
field of health. This is largely explained by the fact that in the Member States health is 
considered to be a matter of public welfare and is covered by a regulatory framework; 
as a result, it is not the subject of lllti-trust measures. 
This situation differs,  for example,  from  that  in  the United  States,  where  com~tion 
. policy  plays  a very  active role  in the  health  sector owing  to the different regulatory 
framew.ork which makea sreater provision for private-sector activity. Taklng into account 
the  difference in  the  overall  approach to the  subject of the model  society  and  social 
dialogue, this diversity in the field of health is expected to continue. 
22.  Community competition policy plays an active part in thepltannaceutical product sector. 
Several matters have been addressed by the Commission in this field. The most sensitive 
aspects are theftnancing_ojnsetli'Cit.andlikvelopment, which is very significant and may 
give  rise  to  inter-company  cooperation  or  public  grants,  as  well  as  major  price 
differentials for drugs in the Community as a result of practices in both the private and 
public sectors. 
23.  Referring to the first of these aspeds, the Commission has recently decided to exempt 
from  the ban on restrictive practices the cooperation qreement under which Merck & 
Co  Inc.  and  the indirect subsidiarity of Rh&te-Poulenc,  Pasteur-lyferieux  (serums and 
vaccines) have joined forces to pursue their EC and EFTA activities relating to vaccines 
for  human use through a new joint company.  This decision,  taken under Article 85  of 
the  EEC  Treaty  and  Article  53  of the  EFT A  Agreement,  is  based  mainly  on  the 
importance of the expected b~ns  for public health in general and the vaccination of 
children in particular. 
As far as State aids are concerned, Article 92 (3) (c) makes provision for the possibility 
of a derogation from the principle of  incompatibility with the common market for aid to 
facilitate  the development of certain activities.  In the field of health, this derogation is 
applied in particular to research and development aid. 
24.  As for the problem associated with medicinal product price differentials, the Commission 
has already dealt with or is in the process of dealing with various matters in such a way 
as to allow parallel imports within the European Union from countries where producers 
are less expensive. 
On one occasion in the past the Commission fined the pharmaceutical concern Sandoz 
Prodotti  Farmaceutici  S.p·.a.  the  sum  of ECU 800 000  under Article 85,  for  imposing 
export  bans  on  its  clients.  It  is  currently  considering  the  case  of a commonly  used 
medicinal product, the price of which is up to three times higher in some Member States 
than in others. 
11 2.4.  Research and tecbooiQD 
i.i··-
25.  The overall objectives of Community Research and Technological Development (RTD) 
policy  are defined in  a chapter of the Treaty on European Union,  and in particular in 
Article  130f.  · 
This policy is carried out by  means of successive Framework Programmes, each made 
up  of Specific  RTD  Programmes  covering  different  research  sectors  and  which  are 
prepared taking account inter alia of  the research needs of  other Community Po.licies and 
of Member States' views, e.g.  on matters such as health protection requirements. 
26.  Health issues are directly and indirectly covered by the 4th Framework RTD Programme 
adopted in  1994 for  a duration of five years with a budget of 12.3  billion ECU.  The 
programmes, research areas and topics most relevant to health include: 
(24) 
(2S) 
(26) 
(27) 
(28) 
Biomedicine  and  Heatth<
24> e.g.  vaccine  development  in  liaison  with  the 
following programme, 
Biotechnology<2'>; 
Agriculture and Fisheries<26>,  e.g. aspects of food safety and hygiene ; 
Envi~onment  and  Climate<
2
7)  (complementing  the  relevant  activities  m 
Biomedicine and Health ) ; 
Telematics Applications in the area of health care<
2•> 
Industrial and Materials Technologies (relevant to the working environment) ; 
Council Decision 94/913/EC  of 15  December  1994  adopting a  specific  programme  of research and 
tecluiological development, including demonstration, in the field of  biomedicine and health ( 1994 to 1998), 
OJ No L 361  of 31/12/94 p.40 
Council Decision 94/912/EC ·of  15  December  1994  adopting  a  specific  programme of research and 
teclmological  development,  including demonstration,  in the field of  biotechnology  ( 1994  to  1998), 
OJ No L 361  of 31.12.1994, p.25 
Council  Decision  94/805/EC  of 23  November  1994  adopting  a  specific  programme  of research, 
technological development and demonstration in the  field of agriculture and fisheries 'including agro-
industry, food technologies, forestiy, aquaculture and rural development (1994 to  1998), OJ No L 334 of 
22/12/1994, p.73 
Council Decision 94/911/EC  of 15  December  1994  adopting a  specific programme  of research and 
technological development, including demonstration, in the field of  environment and climate ( 1994-1998), 
OJ No L 361  of 31.12.1994, p.l 
see CoUncil Decision 94/80 1/EC of 23  November 1994, adopting a specific programme of research and 
teclmological development, including demonstration in the field of telematics application of common 
interest, OJ No  L 334 of 22 December 1994, p.l 
12 Standards,  Measurement and  Testing<
29>,  including standards related to health 
care and the application of legislation on environmental and worker protection; 
The Targeted Socio-Economic Research Programme<
30>  will address the socio-
economic factors  concerning protection of the health  and ·safety .of workers, 
including cross-national  cost-benefit analyses of preventive health and  safety 
policies ;  · 
Scientific and Technical  cooperation with Developing countries(31>,  including 
research on agriculture, environmental protection and health, the latter covering 
work  on  health  systems,  prevention  of predominant  diseases  and  health 
interventions ; 
Nuclear  Fission  Safety  within  the  European  Atomic  Energy  Community 
(EAEC)<
32>,  aims to ensure the safety of all nuclear activities whatever they are, 
including the integration of radiological protection into a global system for the. 
protection of man and the environment. 
The  training  and  Mobility  of Researchers  programme<
33
,  will  continue  to 
provide  support  to  networks  of laboratories,  research  grants  and  Euro-
conferences on health matters. 
27.  Biomedical  and health  research at European Community level  started in  1978 and hu 
grown steadily in size and content, from three research networks then, to around 400 in 
1994, with more than 6 500 research teams in 17 countries, i.e. the European Union plus 
Iceland and Norway. 
(29) 
(30) 
(31) 
(32) 
(33) 
Biomedicine and Health<24> under the 4th Framework Research Programme, with a budaet 
of ECU 336  million covers the following seven target areas: 
Area  1:  Pharmaceuticals research; 
Area 2:  Research on biomedical technology and engineering; 
Area 3:  Brain research; 
Area 4:  Research on diseases with major socio-economic impact; 
Area 5:  Human genome research; 
Area 6:  Public health research, including health services research; 
Council  Decision 94/803/EC of 23  November  1994  adopting a  specific programme for research and 
technological development, including demonstration, in the field of standards, measurements and testina 
(1994 to  1998), OJ No L 334 of 22/12/1994, p. 47 
Council  Decision  94/91~/EC of 1S  December  1994  adopting a  specific  programme of research and 
technological development, including demonstration, in the field of  target socio-economic research (1994 
to  1998), OJ No L 361  of 31/12/1994, p.  77 
Council Decision 941807/EC  of 23 November  1994  adopting  a specific  proaranune of research and  tcchnoloak:a1 
development, including demonstration in the field of  cooperation with third countries and international OIJanizations 
(1994  1o  1998) 
Council Decision 94/920/Euralom of 15  Dec:ember 1994 adopting a specific programme ofresean:h and trainina in 
the field of nuclear fission safety (reactor safety, waste management and radiation protection) (1994 to  1998) 
Council Decision of 1  S December 1994 adopting a specific programme of  research and tcchnoloaical development, 
including demonstration, in the  f~eld of training and mobility of  researchers (1994 to 1998), OJ L 361 of 31.12.1994, 
p.90 
13 Area 7:  Research on biomedical ethics 
Close links are being established between the research programmes, in particular in areas 
4 and 6,  and the Communities action programmes and  activities in the field  of public 
health. Under area 4, 22% of  the overall budget is devoted to cancer, AIDS, .tuberculosis 
and other infectious diseases as well as to occupational and environmental health. These 
topics are a.lso  public health priorities.  · 
Area 6 (public health research), with  10% of the total budget, will underpin the public 
health  initiatives  taken  in  the  context  of Article  129  of the  Treaty.  To  that  effect, 
research will be focused initially on the following,  among other sub-areas : 
Research into methodologies linked to health data on demographic changes, 
morbidity and mortality in the general population and in specific groups, such 
as  socially  deprived  groups,  in  order  to  identify  health  needs,  usi'ng  new 
indicators as appropriate. 
Research into methods of evaluating the effectiveness of  prevention strategies, 
including health education, in the Member States. 
Assessment of the  socio-economic impact and  performance measurement of 
health  policy initiatives,  including  the  development  of health  information 
systems. 
2.5. Education, vocational training and youth 
28.  Until the entry into force of the Treaty on European Union, Community action in  this 
field  was based  primarily on the provisions of the EEC Treaty concerning vocational 
training,  plus where necessary acts adopted by the Education Ministers meeting within 
the Council. It is now based on  Title VIII,  Chapter 3,  of the EC Treaty, which covers 
education, vocational training and youth. 
The objective of Community programmes is to help sustain the quality of education and 
training  by  encouraging  cooperation  between  Member  States  and  the inclusion  of a 
European dimension in teaching. Cooperation takes various forms, including student and 
teacher mobility,  academic recognition of diplomas  and  exchanges of information on 
known problems, particularly through voluntarily created networks of establishments. 
The  Commission  does  not  attempt  to  exercise  a  general  influence  on  the  sectoral 
composition  of such  cooperation  schemes.  However,  health  is  well  represented.  For 
example,  the  Erasmus  programme  has  supported  13  inter-university  cooperation 
programmes in  the fields of public health and health care,  the fight against cancer and 
the prevention of drug addiction, with total funding of ECU 158 million being granted 
to  111  higher  education  establishments.  The  Cornett  programme,  which  above  all 
encourages the strengthening of transnational links between universities and businesses 
in the field of technology, has co-financed the creation of two networks concerned with 
biomedical  engineering  and  biomagnetism  respectively,  as  well  as  training  modules 
covering  subjects  such  as  computerised  planning  for  dealing  with  health  and 
environmental questions or training on questions of health and hygiene at the workplace. 
14 29.  The  Petra  and  Youth  for  Europe  programmes  are  more  directly  involved  in  health 
protection. Petra, which is concemed witl'l vocational training for young people and their 
preparation for adult life, has, helped to finance youth initiative programmes managed by 
young  ~le  themselves.  SO  such  projects;  with  total  financing  of the  order  of 
ECU 240 000,  are  directly  concerned  with  prevention,  covering·  subjects  such  as 
information and counseltiq relating to alcoholism, drug addictiC?n and AIDS, etc.  Petra 
has also qnanced the creation of  training modules and training for 'instructors. Youth for 
Europe supports cooperation and exchanges between young people outside the school 
environment,  111d  here  u  .  well  young  people  are  extensively  involv~ in  setting  up 
projects.  The  result hu been  more than  40  projects mainly  or  partly  eoncemed  with 
health themes,  particularly dru~  alcohol and sexuality, including AIDS. 
2.6. Transport 
30.  In  the  field  of the  Common  Transport  Policy,  health  protection  requirements  are 
addressed  primarily  through  measures  to  improve  transport  safety.  thereby  reducing 
accidents. 
On roads alone, there are SO 000 deaths and some 1.5 million victims of accidents each 
.year.  In  addition,  accidents  on  the  railways,  in  the  air  and  at  sea  contribute  to  an 
enormous hwnan cost, and  a fiunc:ial  cost estimated between  45  and  90 MECU  per 
annum. 
31.  Under the new Treaty provisions, safety is recognised as an integral part of  the Common 
Transport Policy. The Commiuiori hu responded to this significant development with 
a series of  concr~te proposals aimed at raising the level of transport safety generally. 
32.  Particular attention hu been paid to maritime safety, both for the sake of passengers and 
c;rew,  and  to  minimise  the  consequences  arising  from  marine  pollution.  The 
Commission's Communication on a Common Policy for  Safe  Seas(34)  adopted  in  early 
1993  wu followed  by a series of proposals for  the improvement of  sqfety at sea.  In 
particular,  the ·  Commiuion  proposed ·a complementary  measure  to  its  earlier  ship 
reporting proposal(JS) to address all ships in European waters, not just those calling at EC 
ports(36).  In March  1994,  the Commission adopted a proposal  to  render more effective 
throughout  the  Community  port state  control  of vessels<
37>.  The  Council  adopted  in 
November 1994 a DirectivePJ> on the minimum level of training of seafarers which will 
improve the level of  training of  seafarers in recognition  of  the contribution which human 
error plays in accidents at sea. 
33.  Fol~owing the Communication for an Action Programme on Road Safety<
39> in  1993, the 
Commission brooght forward  proposals to hannonise regulations along ,the lines of the 
UN-ECE European Agreement concerning the international carriage of dangerous goods 
(34)  COM(93)66 of 24.02.1993 
(JS>  Directive 93n51EEC of 13.09.1993 
(36)  COM(93) 647 of 17.12.1993 
(3
7)  coM(94) 73 of 16.03.1994 
(JI)  Couacil Directive 94/58/EC of 22.11.1994, OJ No L 319 of 12.12.1994 
<
39>  COM(93) 246 of 09.06.1993 
15 by road (ADR)<
40
> and to improve and ensure compliance through uniform procedures for 
checks on the transport of dangerous goods<
41 >.  The Council adopted in. November 1994 
a Directive<
42>  on the approximation of the laws of the Member States with regard to the 
transport of dangerous goods by road and agreed on a common position on the control 
Directive. 
34.  At  its  "'e~ting in November  1993,  the  Council  approved  the ·commission's Action 
Programme on Road Safety and also decided to establish a Community database on road 
traffic accidents<
43>  that will enable an in depth analysis of the situation for well defined 
Groups involved in such accidents. In addition the Council decided that 1995 would be 
the Year of  the Young Driver, the objective of  which would be to address the population 
· group most frequently involved in road traffic accidents. 
3  5.  In addition to developments in air transport<""> and rail transport<
45>  in the context of the 
Transport RTD<
46> Programme, the Commission's research effort will address transport 
safety  issues.  In  particular the air,  rail,  waterborne and road transport sectors of this 
programme have  sub-areas dedicated  to  safety  issues.  Also within the framework of 
COST (European cooperation in  the field  of scientific and  technical  research)  safety 
aspects will continue to be considered. In particular, three programmes currently in force 
or envisaged  concern  safety,  namely  the  safety  of motorcycle  helmets  (COST  327), 
Requirements  for  road  markings  (COST  331)  and  Models  for  traffic  and  safety 
development (COST 329), and the safety aspects of low floor bus operation and design 
are included in COST 322. 
2. 7. Telecommunications 
36.  Telematics  technologies  can  contribute  to  an· improvement  of health  care  and the 
communication of  health-related information throughout the European Community. The 
main ways in which they can have an impact are on: 
(40) 
(41) 
(42) 
(43) 
(44) 
(45) 
(46) 
improvement of health resources management and administration; 
more efficient provision of  care by practitioners, through the availability of  accurate 
medical data; 
better matching of recipients and potential donors for organs and tissue transplants; 
seamless medical  care across borders thanks to an adequate flow of information 
between health centres and administrations; 
availability  of expertise  regardless  of the  location  of patients  with  the  help  of 
telemedicine; 
use of commonly agreed  sets of computerised medical  records,  including patient 
data cards; 
COM(93) 548 of 24.11.1993 
COM(93) 665 of 15.12.1993 
Council Directive 94/55/EC of 21.11.1994, OJ No L 319  of 12.12.1994 
Decision 93/704/EC of 30.11.1993 
COM(93) 406 of o  1.09.1993 
COM(93) 678 of 15.12.1993 
Council Decision 94/914/EC of 15  December 1994  adopting  a specific  programme for research and technological 
development, including demonstration in the field of transport (1994 to  1998), OJ L 361  of 31  December 1994, p.  56 
16 improvement on  the  education  of health  care  providers,  managers,  and  citizens 
through the use of advanced learning technologies; 
better geographical coverage of scattered or isolated populations; 
better integration of the disabled  and  the elderly  through technologies including 
telematics. 
The above points are expected to result from the Telematics Applications Programme<2•>, 
in  its sectors of health care (formely AIM),  education and training (formely DELTA), 
disabled  and  elderly  (formely  TIDE),  administrations  (formely  referred to as  ENS), 
urban and rural areas and research networks ; the budget for the period 1994-1998 in the 
area of health care amounts to ECU  135  million.  Other aspects of potentially positive 
impact on  health  include:  telematk:s  for  the  environment,  telematics for  multimodal 
transport and teleworking  (the latter is covered under both the Telematics Applications 
Programme and the Advanced Communications Technologies and Services Programme). 
3  7.  Another important aspect of  the Telematics Programme is the improvement of  biomedical 
research practices and outcomes owing to  better access to information databases and 
specialised  literature  sources,  as  a  result  of the  work  in  the  Libraries  Sector of the 
Telematics Applications Programme, and the IMPACT and VALUE Programmes. 
38.  With  regard  to  hand-held  radiotelephones,  the  Commission  has  recently  presented  a 
Green  Paper on  mobile  and  personal  communications  in  the European  Union  and  a 
Communication  to the  European  Parliament and  the Council  on  consultation  on  this 
Green  Paper,  together  with  a  proposal  for  a  Council  resolution  on  the  further 
development of such communications<
4
7).  Comments on the Green Paper have confirmed 
that the public is concerned with the potential hazards to humans on the one hand, and 
the potential  for  electromagnetic interference with other electronic equipment such as 
safety devices,  pacemakers and hearing aids on the other. 
(47) 
As  regards  hazards  to  workers,  the  Commission  has  recently  presented  a  modified· 
proposal for a Council  directive, based on Article 118a as mentioned in section 2.10.3 
of this report. As regards the general public, the Commission noted that there was broad 
support for the setting up of action programmes to assess the impact of radio frequency 
radiation on human health and safety and to accelerate the development of the necessary 
safety standards. 
The  Commission  accepts  that  there  is  a  need  for  further  research,  surveys  and 
investigations in the area of biological effects of and exposure to electromagnetic fields 
in the frequency range concerned by mobile and personal communications. In particular, 
urgent work needs to be undertaken with regard to the so-called "athermal effects" so as 
to obtain sound data on the role of electromagnetic fields at these frequencies on cancer 
initiation or tumour promotion.  The Commission will  support such work,  both in  the 
context of action programmes in the field of public health and in the context of COST 
programmes. 
Finally, the Commission is supporting programmes for the establishment of standards in 
this field aiming at translating into operational quantities and measurement methods and 
COM (94)  145 final of 27.4.1994, and COM (94) 492 final of 23.11.1994 
17 procedures  the  limits  and  requirements  laid  down  by  Community  legislation.  The 
Commission  has  already  forwarded  standardisation  mandates  to  CEN/CENELEC 
concerning the development of  standards for thermal effects and of a programme of  work 
on future standards for possible athermal  effects. 
39.  A related area of  policy development is work towards the so-called "Information Society" 
which is  in~ended to consider the indications of  the development of new information and 
telecommunications technology for  society  and  how it can be used  to help  overcome 
social problems. In this context the health consequences of  these new developments will 
also be carefully considered.  · 
2.8. Consumer policy 
2.8.1  General product safety 
40.  Directive  92/59/EEC  on  general  product  safety,  adopted  by  the  Council  on 
29 June 1992<
4•> entered into force on 29 June 1994. This Directive, which applies insofar 
as  other  Community  product legislation  do  not lay  down  safety  provisions,  obliges 
producers  to  place  only  safe  products  on  the  market.  Producers  shall  also  provide 
consumers with the relevant information to enable them to assess the risk inherent in a 
product and have a system for taking appropriate action in case of risks.  Distributors 
shall  act with due care,  as  professionals, to ensure compliance with the general safety 
requirement. 
The Directive imposes a duty  on Member States to adopt the necessary provisions to 
make  producers  and  distributors  comply  with  their  obligations,  and  to  establish 
authorities  to control  products  on  the  market.  The Directive also  lays  down  a  rapid 
exchange of information procedure for products presenting a serious and immediate risk 
to the health or safety of consumers. 
41.  The  objectives  of the  European  Home  and  Leisure  Accident  Surveillance  System 
(EHLASS) are to organise and coordinate the collecting of data on home and leisure 
accidents  with  a  view  to  promoting  accident  prevention,  informing  and  educating 
consumers  so  that they  make better use  of products,  and if necessary  improving the 
safety of consumer products. 
(48) 
(49) 
The system foresees two ways of collecting data.  Nine Member States have chosen to 
collect the data through a network of hospitals while three Member States (Germany, 
Luxembourg and Spain) use the method of household surveys.  For the continuation of 
this system the Commission in February  1994 adopted a proposal for the period 1994-
1997, which was subsequently adopted by the Council and the European Parliament on 
'\December 1994<
49>. 
OJ N' L 228, 11.08.1992, p. 24 
Council and European Parliament Decision 3092/94/EC, OJ No L 331, 21.12.1994, p.l. 
18 42.  Financial support may be given---to. infonnati.on campaigns and  studies covering certain 
upects, e.g. actions coneeming sPecial risk groups such as children and elderly people 
or pro(luctslaetivities with a high level  of risk which require special attention. 
l.B.l.  Safety of SQMU!ti$ ....  ucg 
43.  The  Cosm.,Ucs  DirectiVe  76n61/EEC
50>,  as  most  recently  amended  by  Commission 
Directive 94132/EEC
51> of 29 June  1994, is designed to safeguard human health in the 
context of the establishment and ·functioning.of the internal market. 
This Directive lays d~  at Coaamunity level, the-regulations which must be observed 
as  regards the composition,  labelling and pDC/alging of COII1letic  products.  It includes 
various technical  annexes Contliiing lists  of prohibi~ed substanc:es,  substances  which 
cosmetic products muat not Colltain-except subject to the restrictions and conditions laid 
down, and three positive lim reliting to colouring agelrta, preservatives ana uv filters. 
These lists are replarly amendecho adapt them to technical progress,  on the basis of a 
procedure involving a COIIfllfittn on Adaptation to Technical Progress, which evaluates 
1he  safety  of eKh su1mance  ill  terms of human  health  after  consulting  a Scientific 
Committee on Cosmeto/Of)l. 
44.  On  29 June  1994 the Commiuion adopted the  17th Directive adapting the Cosmetics 
Directive to technical progress, 
1994 also saw the continuation of work relating to implementation. of Council Directive 
93/35/EEC of 14  June  1993,  amending  for' the  sixth  time  Directive  76n68/EEC,  in 
particular so u  to be &ble to cstabliih, within the required time, a list of  ingredients used 
in cosmetic products, conditiou and cnteria relating to the confidentiality of certain data, 
and  a  report  on  pro,en  in  the ·development,  validation  and  legal  acceptance  of 
alternative testing methods to thoie involving experiments on animals. 
·1.8.3.  Safety of toya 
.  ' 
45.  In this field,  the health protection of users. e.g.  children,  or third. parties,  is taken into 
account  in  the  Counc;il  Directive -88/378/EEC  adopted  on  3  May  1988  on  the 
· approximation of the.laws'of the Member States concerning the safety of toys<'
2>.  This 
Directive foresees in particular tafety requirements concerning health hazards linked to 
chemicals compounds~  ,_  ,  . 
.  ..,... 
As  a generll  principle,  toys  ttn~St comply· with  the· relevant  Community  legislation 
relating  to  certain  ~lies  of products  or  to  the  prohibition,  restriction  of use  or 
labelling  of  certain  ··~acrous  ,. substances  and  pr~parations .  (such  as  Directives 
671548/EEC  Qll  d'apr~i aub-.nces  and: 88/379/EEC  on  dangerous  preparations). 
Moreover,  the- autborised.~bioaYIHII:rility of heavy  metals  (antimony,  arsenic,  barium, 
cadmium. chromium, lead,  meraury', selenium) is listed in Directive 88/378/EEC. 
.  . 
cso>  ·  OJ No 'L 162, 27.9.1976. 
(SI)  OJ No L 181, 15.7,1994. 
(Sl)  OJNe L 187, 16.07.ltU. 
19 46.  In  order  to  facilitate  proof of conformity  with  the  essential  requirements  for  health 
protection,  the  Commission  has  given  mandates  to  the  European  Committee  for 
Standardisation  (CEN)  to  establish  harmonised  standards  at  European  level  on  the 
migration of certain elements (e.g.  the heavy metals listed in the directive on safety of 
toys),  experimental  sets for chemistry and  related activities, and  chemical. toys or sets 
other than experimental sets (such as photographic development sets).  Another mandate 
in this fiel4 will be given by the Commission to CEN in the course of 1995 for a new 
European standard on organic chemical compounds. 
2.9.  Economic apd social cohesion 
2.9.1.  European ReJional Development Fund  (EBDF) 
47.  Investments  in  education  and health  in  Objective  1  regions  (regions  lagging  in 
development, with a GOP generally less than 75% that of the Community average) are 
now  included  in the  scope  of the  ERDF  following  the adoption  by  the  Council  on 
20.07.1993 of  the revised Regulations governing the Community's Structural Funds; the 
scope  of the  ERDF  remained  otherwise  broadly  the  same  as  before.  The  Council 
Declaration accompanying these regulations gave priority in the field of  health to basic 
health facilities in under-equipped areas. 
48.  Member States submitted a total of 17 Objective 1 plans to the Commission which were 
assessed on the basis of the following specific key  criteria : the quality of the plans in 
relation to the new regulations ; the quality of  the proposed strategy and relevance of the 
measures ; the introduction of innovation.  As part of this process an analysis has been 
undertaken to assess how the Council Declaration relating to health has been interpreted 
in the Objective 1 plans. 
Given the very recent introduction of the possibility of using ERDF in the health field, 
it might be expected that the number of projects submitted would be relatively limited. 
In general terms the use of the extended scope of ERDF in the Objective 1 regions has 
been primarily confined to hospital/health centre construction and renovation in the four 
Cohesion Fund  countries (Ireland,  Greece,  Portugal  and  Spain).  Other measures  also 
concern  the  purchase  of medical equipment.  The  projects  agreed  amount  to  around 
"MECU  2,000  with  a  total  proposed  C.ommunity  contribution  of  "MECU  1,350 
representing an average co-financing rate of 65  %.  (The total ERDF budget for 5 years 
is  around  100  BECU).  The  projects  are  located  in  Belgium,  French  Overseas 
Departments, Greece, Ireland, Portugal and  Spain. 
49.  However,  among the projects submitted and  financed  some were related to improved 
training facilities and  training of  health staff in areas such as public health as well  as 
prevention and health promotion facilities and actions. 
In  Portugal  the third of the three  measures  proposed  concerns the provision of basic 
training for health staff as well  as  retraining of existing personnel  for the demands of 
modem  medicine.  In  the  French  overseas  Department  of Martinique  the  economic 
20 insertion project includes measures to facilitate the access of marginalized populations 
to health services. 
In  Greece  in  addition  to  the  modernisation  of the  infrastructure .of health  services 
(including the setting up of a national centre for emergencies and telemedecine services) 
and of the management of hospitals and the training and retraining of health staff, it is 
foreseen  to establish  a  national  blood  transfusion  centre  contributing  significantly  to 
improving 
1
blood safety and availability. 
A particular project with relevance to prevention is to be found in the programme for 
Hainaut,  Belgium.  This  relates  to  the  prevention  of major  diseases. (cardiovascular 
diseases,  liver cirrhosis,  cancer of the  uterus  and  pulmonary  tuberculosis).  For these 
conditions the incidence rate is more than twice the national average.  The project aims 
at improving the health situation of the  most affected  populations and  at decreasing, 
through prevention actions, the economic and social cost of  these pathologies. The health 
structures, professionals and NGOs of five cities will be involved in the 6 ~ear project 
of 5 MECU with a 500/o financing by the ERDF. 
2.9.2.  European Socjal Fund (ESF) 
50.  The reform of structural policy has led to far-reaching changes in the tasks and activities 
of die ESF.  In this new situation the ESF takes action to support a policy which aims 
both at encouraging active measures in  the employment market and  at  improving the 
general conditions for riiaking full use of  the human factor. This is a policy which gives 
·much clearer recognition than in the past to the importance of intersectorallinks between 
education/training/employment and other forms of human resources development such 
as health protection. 
51.  The ESF's health-related objectives may  be identified in the new Community  Support 
Frameworks (CSFs) for  1994-99; which have been established in  partnership with the 
responsible authorities in the Member States. The main aims of the policy adopted in this 
field may be summarised as follows: 
52.  a)  To  strengthen health system structures 
This aim is specific to the Community's regions which are lagging behind (Objective 1 
regions) and consists in reducing the existing disparities between these regions and the 
most developed ones. 
To achieve this, the Stru9tural Funds provide support for national  policies designed to 
modernise health systems by alltX:ating substantial sums either to improve infrastructure 
and equipment (ERDF) or· to develop the human potential employed in the sector (ESF). 
More specifically, ESE action is Concentrated firstly on initial and continuing training for 
. health professiOnals, placing emphasis on the promotion of qualifications linked to new 
medical  technologies  and  new . prevention  services,  and  secondly  on  training  for 
administrative staff in order to facilitate the application of new management methods. 
21 53.  b)  To  facilitate  the  social  and occupational  integration  of categories  of persons 
exposed to the phenomena of  drug addiction and alcoholism 
This is an  integral part of a much broader policy to assist persons expased to exclusion 
from  the  labour  market.  The aim  is  twofold:  initially  to combat the  isolation  of the 
groups  of persons  exposed  to  dnig  addiction/alcoholism,  and  subsequently  to  create 
genuine  prospects for integration through  measures  such  as  information,  counselling, 
training and job creation. 
54.  c)  To promote health education in schools and training centres 
As  part  of its  support  for  teaching  and  initial  training,  the  ESF  can  contribute 
significantly to promoting health education.  To date,  initiatives in this area have been 
few and far between, which is why the ESF is planning to encourage national authorities 
to introduce specialisation training for teachers/instructors or specific measures in schools 
or training centres. 
2.1 0.  Social dimension 
2.10.1.  Employment 
55.  In the field of employment and labour market the main involvement with health policy 
to date has been via the directive<SJl  on protection of  pregnancy and maternity at work. 
Pregnant women and women who are breastfeeding or who have recently given birth are 
entitled  to  protection  from  chemical,  physical  and  biological  agents  and  industrial 
processes which might put them at risk. 
These hazards are listed in two. categories. The first category includes those agents and 
processes  which  can  potentially  be  hazardous,  though  the  actual  risk  depends  on  a 
specific job description. Examples include physical conditions such as work that involves 
lifting,  noise,  tiring  movements  and  postures,  exposure  to  radiation,  exposure  to 
biological agents or to chemical agents such as  mercury and carbon monoxide.  Mental 
and physical fatigue and other types of stress are also covered. 
The second category lists risks considered to be particularly harmful, such as  exposure 
to  toxoplasma and rubella virus, to lead and  lead derivatives,  and underground mining 
work,  or work  in  pressurised  enclosures  and  underwater  diving.  These  hazards  are 
prohibited. 
56.  Employers  must  accordingly  adjust  the  working  conditions  of exposed  workers,  or 
transfer them as appropriate. If this is not possible, workers must be granted paid leave. 
(53) 
Guidelines setting out these hazards in detail are being drawn up by the Commission in 
consultation with the Advisory Committee on Safety,  Hygiene and Health Protection at 
Work and the Member States. 
Council Directive 92/85/EEC, OJ No  L 348, 28.11.1992, p.l. 
22 2.10.2.  Social security and social action 
57.  . Social Action 
The White paper on European Social  Policy<
54> refers to the significant links between 
public health and social and environmental policy. These include the adverse effects of 
poverty, unemployment and social  exclusion on health and the increasing pressures on 
health and social protection systems caused by demographic changes, notably the ageing 
of  the population; the role of preventive and rehabilitative health programmes in fostering 
social  integration;  the  impact of environmental  conditions  on  public health;  and  the 
specific health problems and needs arising from increased mobility within the Union and 
migration into it. 
A report on the demographic situation in the Community<
55>,  in accordance with Article 
7  of the  Social  Protocol  appended  to  the  Maastricht  Treaty,  was  adopted  by  the 
Commission in  December  1994.  This  report  analyses  phenomena  such  as  population 
ageing, migration, and the breaking up of family structures, which are at the root of new 
needs in terms of health, prevention,  meeting the cost, and social protection . 
58.  . Social Protection 
Council Recommendation 92/442/EEC on the convergence of  social  protection objectives 
and  policies has laid down common objectives as guidelines for Member States' policies. 
In relation to sickness, the following three objectives are set out: 
a)  under conditions determined by each Member State, to ensure for all persons legally 
resident within the territory of the Member State access to necessary health care as 
well as to facilities seeking to prevent illness; 
b)  to maintain and,  where necessary, develop a high-quality health care system geared 
to the evolving needs of  the population, and especially those arising from dependence 
of the elderly, to the development of pathologies and therapies and the need to step 
up prevention; 
c)  to organise where necessary the rehabilitation of  convalescents, particularly following 
serious illness or an  accident, and their subsequent return to work. 
59.  In  April  1994,  following  on  from  this  Council  Recommendation,  the  Commission 
adopted the first report on "Social protection in Europe"<
56>,  which sets out to develop the 
(54} 
(55) 
(56} 
. COM (94) 333 of 27 July  1994 
COM(94) 595  of 13.12.1994. 
COM(93) 531  of 26.4.1994. 
23 exchange of information and analysis of Member States' policies. Chapter 7 reviews the 
measures implemented by  Member States in  recent years to contain the rise in  health 
care costs, a preoccupation common to all  Member States.  The subjects to be covered 
by  the  second  report  on  "Social  protection  in  Europe",  due  to appear  during  1995, 
include an  analysis of the impact of these  measures on the quality· of the health care 
system and on equal access to care and prevention for all  popula~on groups. 
2.10.3.  Health and  safety at work 
60.  In  this field  much work  has been  performed  on  health  and  hygiene at work and  the 
prevention of occupational diseases. 
The Commission has implemented three action programmes on safety and health at work. 
since  1978,  which  were  all  the  subject  of Council  resolutions.  The  third  action 
programme was an essential complement to the social aspects of the development of the 
internal market. It was based on three fundamental concepts: 1) the need to push on with 
improving the safety and health protection of workers on a broad front; 2) the obligation 
to ensure that workers have adequate protection from  the risks of work accidents and 
occupational diseases ; and, 3) the will to complement the internal market with measures 
on the safety and health protection of workers. With these three objectives in mind, the 
Commission decided to devote considerable effort to legislation, although the principles 
of providing all  necessary information to workers enshrined in the earlier programmes 
was retained. 
As concerns legislation, the principles of the legislative programme were to: 
• cover a maximum number of risks with a minimum number of directives, in order to 
avoid fragmented legislation; 
- cover the specific requirements of certain high-risk activities or sectors and of certain 
categories of workers who are particularly vulnerable; 
- ensure consistency between Community provisions adopted as part of the completion 
of the  internal  market  (Article  100a},  which  lay  down  the  main  safety  and  health 
requirements to be met in the design, manufacture and marketing products, and directives 
adopted on the basis of Article 118a, which relate to their use at the workplace. 
61.  Several directives are of particular relevance to public health.  Article 14 of the Council 
Directive of 12 June 1989 on the introduction of measures to encourage improvements 
in the  safety and health ofworkers at  work (89/391/EEC)<m  provides for the health 
surveillance of  workers appropriate to the health and safety risks they incur at work. This 
requirement  is  set  out in  more  detail  in  several  individual  directives.  For example, 
Council Directives 92/91/EEC<'•> and 92/104/EEC<
59>  on the minimum requirements for 
improving the safety and health protection of  workers in the mineral-extracting industries 
(drilling operations and surface/underground workings respectively) make provision for 
health surveillance for all workers before they are assigned to duties related to extraction 
activities and subsequently at regular intervals (Article 8).  Council Directive of 29 May 
1990  on  the  minimum  safety  and  health  requirements  for  work with  display  screen 
(57) 
(58) 
(59) 
OJ No L  183, 29.6.1989, p.  1. 
OJ No L 348, 28.11.1992. 
OJ No L 404, 31.12.1992, p.  10. equipment (90/270/EEC)'
60> entitles workers to eye and eyesight tests and,  if necessary, 
an ophthalmological examination (Article 9). Finally, Council Directive 92/29/EEC<
61
> of 
31  March  1992  lays down the minimum  safety  and  health  requirements for improved 
medical treatment on board vessels. 
62.  In  1994 the Commission presented amended  proposals for  Council  Directives on the 
protection 9f the health and safety of workers from the risks related to chemical agents 
at work<
62
> (liJ> and on the minimum health and safety requirements regarding the exposure 
of  workers to the risks arising from physical agents<
64>  <
65>.  The latter introduces protective 
measures  against  the  risks  resulting  from  three  further  physical  agents  (mechanical 
vibration, optical radiation, and electro-magnetic fields and waves) and amends certain 
provisions on protection against noise. 
On  18 July  1994 the Council adopted a Regulation<
66> establishing a European Agency 
for Safety and Health at Work,  located in Bilbao.  The Agency's main tasks will  be to 
collect and  disseminate technical,  economic  and  scientific  information  on  health  and 
safety  at work and  to promote and  support exchanges of information and  experience 
between Member States. 
As announced in its Communication on the medium term social action programme<
67> the 
Commission will  present a  communication,  including a draft decision,  on  the Fourth 
Programme concerning  Safety,  Hygiene  and  Health  Protection at  Work ( 1995-2000) 
setting out the measures necessary in this area, and including a proposal  for a specific 
programme SAFE to promote better awareness of health and safety legislation in small 
and  medium-size  enterprises.  These  measures  will  be  complemented  by  actions 
undertaken  under  the  proposed  Community  action  programme  on  health  promotion 
{1995-1999)<
6•>. 
2.11.Healtb protection and  the environment 
63.  The physical environment has a major direct influence on human health not only through 
contaminated  air,  water  and  soil  but  also  through  the  impact  of  the  biological 
environment on food  supply and on disease transmission mechanisms. 
(60) 
(61) 
(62) 
(63) 
(64) 
(65) 
(66) 
(67) 
(68) 
{69) 
DG XI  policy  in  implementing the  "European Community Programme of Policy  and 
Action  in  relation  to  the  Environment  and  Sustainable  Development" 
(Fifth Programme)<
69
>  aims  to  develop  a  strategy  which  integrates  environmental 
considerations in  other policy areas and  broadens the range of instruments that can be 
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25 used  to achieve increased  and  more effective environmental  protection and  to  ensure 
sustainable economic growth and more employment. 
Environmental factors that could impair human health include: 
climatic change and global warming 
stratospheric ozone· depletion  · 
atm~spheric ozone concentration 
high' concentration of sulphur and nitrogen oxides and of airborne particulates 
acidification of soils 
pollution of soils and of groundwater 
exposure to·man-made noxious chemical agents and substances. 
64.  The Community is playing a major role in the wider international area and has taken an 
active  part  in  the  United  Nations  Conference  on  Environment  and  Development 
(UNCED) and participates in the Commission on Sustain.able Development (CSD) set up 
at UNCED.  The European Commission actively  participated in the Second European 
Conference  on  Environment  and  Health  in -Helsinki  on  20-22  June  !'994  and  is 
represented  in  the European Environment and  Health  Committee (EEHC),  which has 
been established to take forward work on the follow-up to the Helsinki conference. 
2.12. Eperc policy 
65.  The production and use of energy can have either a direct or indirect effect on health 
conditions.  This  is  why  - although  there  is  still  not  a  common  energy  policy  at 
Community level -the European Commission, together with the parties concerned, has 
since 1986 been working on the components of a Community energy policy which have 
contributed, among other things, to an improvement in living standards.  . 
66.  One of the aims  of the  strategy is to  promote the well-being of citizens through the 
efficient and rational production and use of  energy, thus having a positive impact in the 
area of public health. 
The energy sector provides for direct measures to protect public health in its different 
areas of concern, for example through the Safety and Health ~ommission  for the Mining 
and Other Extractive Industries, which establishes specific rules and obligations relating 
to worker protection that are considered to be among the most demanding in the world. 
The Euratom Treaty, moreover, dedicates its third chapter to health protection. 
67.  Since the  production and  consumption of energy  may  have a  negative impact on  the 
environment and adversely affect living conditions for the general population, over the 
years  more  efficient  and  sophisticated  measures  to  protect  the  environment  in  the 
hydrocarbons, coal and nuclear sectors have been developed.  These measures, although 
not directly aimed at public health, certainly have a positive effect on it.  · 
Programmes such as. THERMIE, AL TENER, SAVE, etc.  have also been developed with 
a  view  to  improving  technology,  using  energy  rationallly  and  efficiently,  and  using 
renewable resources.  The aim  is to achieve better living conditions in general and thus 
to help improve public health. 
26 2.13.  Aaricultural policy 
2.13.1.  General objectives 
68.  The Commission is involved in the harmonisation of essential  health  requirements in 
relation to animals, products of animal origin and products of plar:tt origin. Such actions 
are necessary in order to avoid the  placing on  the  market of products which would 
present a  hazard to human and  animal  health,  and  to  ensure free  movement of such 
products. 
2.13 .2.  Legal  context 
69.  Harmonisation of health rules for animals,  products of animal  origin and products of 
plant origin has been  established to protect the  consumer and the livestock populaiion 
of the  Community  and  to  ensure  free  movement  throughout  the  Community.  This 
objective falls within the terms of Article 39 of the Treaty for the agricultural products 
mentioned in Annex II of the Treaty. 
As the Court has held in its judgements<
70>,  Article 43  of the Treaty is the appropriate 
legal basis for any legislation concerning the production and marketing of agricultural 
products listed in Annex II to the Treaty which contribute to the achievement of one or 
more of the objecti.ves of the Common Agricultural Policy set out in Article 39 of the 
Treaty. 
2.13.3.  Strategy 
70.  a)  Veterinary control strategy is based on the following principles : 
(70) 
- protection of human health and  production of wholesome food in  the hygienic 
processing, storage and distribution of raw animal products. A prerequisite is for 
food-producing animals to be in good health.  In addition, a high "environmental 
health" level, i.e.  a hygienic state in the environment around these animals and 
in agricultural inputs, is equally important, 
- health  checks  on  animals  and  animal  products  at  the  internal  borders  of the 
Community have been replaced by controls and checks carried out at the places 
of origin.  Spot checks should be also carried out at the place of destination  or 
elsewhere when there is reason to suspect that a problem exists, 
- cooperation and coordination of measures, 
- a scientific basis for the legislation and implementation decisions underpinned by 
the Community's own independent scientific committees and liaison laboratories, 
- cooperation between the various services involved through exchanges of national 
officials, training courses, seminars, etc ... 
23  February  1988 in cases 68/86 and 131/86 
27 - information technology, ADNS, ANIMO and SHIFT systems, 
- provision of a safeguard clause to enable rapid action to prevent a serious animal 
health or public health incident, 
- financial assistance through a Community contribution to programmes for disease 
eradication and control, to the work of liaison and reference laboratories and to 
seminars and training courses, 
- ensuring  that  the  conditions  for  the  placing  on  the  market  of animals  and 
products originating from third countries are equivalent to those applied by the 
Community. 
71.  b)  Strategy in the field of  plant products: 
- to ensure that plant protection products are, when properly used, safe to human 
and animal health and the environment, 
- to ensure that levels of contaminants arising from agricultural production are safe 
for consumers, 
- to facilitate cooperation and coordination of measures, 
- to provide a science basis for legislation using independent scientific committees 
as necessary. 
c)  Legislative action 
72.  This entails the utilisation of a variety of different legal mechanisms covering the three 
major segments of the production cycle : upstream (pre-harvest), on-farm (production-
harvest) and downstream (post-harvest processing). 
73.  The  UPSTREAM  elements  cover  regulation  of agricultural  inputs  (e.g.  pesticides, 
feedingstuffs),  use of veterinary medicines,  additives in  feedingstuffs,  production aids 
such as BST, wastes and contaminants. 
74.  The ON-FARM elements include the regulation of animal and plant health,  conditions 
of production,  including  aquaculture  animals,  for  public  health  purposes.  Important 
zoonoses  such  as  rabies,  TB,  brucellosis and  salmonella are  subject to  Community-
supported programmes of eradication or control. The objective is clear- a high standard 
of health  on  the  farm  and  at  primary  production  level.  This  approach  continues  to 
require common strategies and implementation, e.g.  on disease control. 
75.  The POST-HARVEST elements cover the regulation of the movement conditions for 
animals and animal products, including food hygiene until it reaches the consumer. This 
has  required  legislation  on  food  production hygiene,  with  specific provisions for  the 
different product sectors such as meat, fish and dairy, tailored to the particular risks each 
28 product poses, and requirements on the examination, monitoring and surveillance of and 
testing for the presence of microbiological and chemical contaminants. 
2.13.4.  Application 
76.  a)  Organisation of  controls and inspections 
77. 
(71) 
Throughout health legislation, the principal is maintained that the prime responsibility 
for checking compliance with Community requirements lies with the manufacturer and 
producer. They must ensure that the products of animal and plant origin they produce 
do not present hazards by carrying out the necessary checks on products and by applying 
the  HACCP  principles  (Hazard  Analysis  Critical  Control  Points).  The  role  of the 
competent  authorities  of the  Member  States  is  to  ensure  that  the  Community 
requirements are properly applied by control of  Community health programmes, farming 
units  and  their  inputs,  food  production  establishments,  production  processes  and 
subsequent movement of  the product concerned. In certain cases, a special role must be 
attributed  to officials  of the  competent  authority  which  have  to  carry  out  specific 
inspection and certification tasks . 
b)  Special actions and campaigns 
•  Tobacco sector 
The  new  Common  Organisation  of the  Market  (COM)  in  raw  tobacco  (Council 
Regulation (EEC) No 2075/92) takes extensive account of the health factor: 
- The Community Fund for tobacco research and information has been set up under this 
new system. Its objective is to finance measures to discourage and provide information 
on smoking as  well  as  scientific research with a view to steering tobacco production 
towards the least harmful varieties. 
The Fund is financed by tobacco planters through a deduction from the premiums paid 
to them. 
The rules for its application are set out in Commission Regulation (EEC) No 2427/93 
of 1 September 1993(71>. 
-Article 14 of the Council Regulation makes provision for a three-year programme for 
the conversion of  plantations of Mavra, Tsebelia, Forcheimer, Havana lie and hydrids 
of Geudertheimer tobacco to varieties more in line with market requirements or to other 
agricultural crops.  This programme was launched beginning with the 1993  harvest. 
-Finally, the new COM is based on a quota system limiting Community production. 
OJ No L 223, 2.9.1993 
29 78.  •  Wine and spirits sector 
Common wine and spirits policy is  primarily a quality  policy.  The measures taken at 
Community level  are designed to safeguard product quality by  adopting descriptions 
relating to the production of these products.  It is not just a question of preserving the 
intrinsic quality of wines and spirits, but also of fixing maxmimum contents of certain 
substances: which affect consumers' health  (volatile acidity,  S02,  etc.).  Other specific 
provisions have been adopted solely to protect consumers' health, e.g. the ban on the use 
of lead in sealing capsules. 
79.  On a different note,. there is clearly a rather delicate link between alcoholic beverages 
such  as  wines  and  spirits  and  health.  Excessive  consumption  of such  products  is 
obviously harmful to health. Wine consumption in the European Community is steadily 
falling (by approx. 2% per year), and consumption of spirits is generally declining. The 
COM measures for wine are aimed at stabilising the market by adapting supply to this 
80. 
81. 
(72) 
change in demand (grubbing, yield limitation, distilling of  surplus production, etc.). Most 
distilled products are not used in the spirits sector, but find their way into other sectors 
(cosmetics,  pharmaceuticals,  paints,  etc.) and even  into the fuel  industry,  in  order to 
avoid distortions of competition or interference with traditional markets. In view of the 
rather  precarious situation of a large number of wine growers in  the  Community,  it 
would seem advisable, while continuing to pursue a policy of health protection, not to 
adopt  extreme  measures  which  would  be  likely  to  aggravate  the  market  imb~ance 
without giving producers enough time to adapt to this situation. 
•  Quality milk and beef and yeal promotion proarammes 
These programmes each contain a nutrition component, which is more advanced in the 
case of milk than meat.  The promotion programmes for milk (Regulations (EEC) Nos 
585/93 and 3582/93) include chapters on nutrition focusing on the benefits of foodstuffs 
containing  milk  (calcium  and  osteoporosis,  growth  in  young  children,  nutrition  for 
pregnant women).  Since  1990 (Regulations Nos  1000/90 and 465/92) the Community 
has also financed the setting up of scientific databases covering the nutritional qualities 
of  milk  with  regard  to  certain  public  health  problems  (growth,  osteoporosis, 
cardiovascular disease) as well  as data dissemination. 
•  Oliye oil  promotion proarammes 
These programmes include a section on the dissemination of scientific knowledge on the 
nutritional value of the product to the medical and paramedical  professions and to the . 
general public<'
2>. 
Conununication  "from the Commission on the 6th action progranune (end 1994-end 1996) to promote the 
consumption of olive oil, COM(94) 86 final of 22.03.1994. 
30 2.14  Fisheries 
82.  There are currently a number of different activities relating to the protection of human 
health under the Common Fisheries Policy . 
During the period 1991-1994 the Commission distributed a total.  budget of more than 
ECU 230 p1illion among the Member States for the improvement of fishery  product 
marketing and processing conditions.  One of the priorities of this investment was to 
bring marketing and processing establishments into line  with health standards.  These 
guidelines remain in force under the reformed Structural Funds and are coordinated with 
and incorporated into other Community policies. 
83.  In  1993 the Commission also provided funding to the amouht of ECU 0.2 million for 
measures in certain Member States to promote the consumption of  fishery products on 
the basis of an  epidemiological  medical  study  illustrating the positive impact of an 
increase in the consumption of such products on health in general and in particular on 
the risk of cardio-vascular disease resu!ting from  eating habits. 
84.  Several projects relating to hygiene and fishery  products were also financed under the 
AIR research programme between 1991 and April 1994 (total funding ECU 3.8 million), 
and  additional  studies  are  planned.  Furthermore,  in  view of the  importance  of the 
consumption of fishery  products for  health,  special  emphasis will  be placed  on this 
aspect in the measures designed to promote the consumption of fishery and aquaculture 
products. 
2.15.  A people's Europe 
2.15.1. Taxation 
85.  As  regards tax rates on  manufactured tobacco products  and  alcoholic beverages,  the 
Commission is required by  Article 4  of Directive 92/79/EEC,  Article 4  of Directive 
92/80/EEC and Article 10 of Directive 92/82/EEC to carry out a review of rates every 
two years,· taking account of the proper functioning of  the internal market and the wider 
objectives of the Treaty.  The first  report<
731  is  being prepared and  is  expected to  be 
transmitted by the Commission to the Council  and European Parliament in  the near 
future. 
86. 
(73) 
(74) 
2. 15.2.  Public health 
On  the  basis of Article  129  of the Union  Treaty,  the  Commission  has  presented  a 
Communication on the  framework for  action  in  the field  of public  health<
741
.  In  this 
connection four priority action areas necessitating specific programmes were identified 
in  1994: 
COM(94) 484 
· COM(93) 559 final of 24 November 1993. 
31 a)  the  fight  against  cancer,  for  which  the  Commission  adopted  a  proposal  for  a 
European Parliament and Council  Decision<
7S>  adopting an action plan 1995-1999 
to combat cancet
76>. 
b)  the  prevention  of  AIDS  and  other  communicable  diseases,  for.  which  the 
Commission, on 5 October 1994, adopted a proposal for a European Parliament and 
Council Decision(7
7>  adopting a Community action programme on the prevention of 
AIDS. and certain other communicable diseases<
7•>. 
c)  prevention  of drug  dependence,  for  which  the  Commission,  on  21  June  1994, 
adopted.a proposal for a European Parliament and Council Decision<
79
> adopting a 
programme of Community  action  on the prevention of drug dependence  (1995-
2000)<10>. 
d)  health promotion, information, education and training, for which the Commission 
adopted a proposal for a European Parliament and Council Decision<
11
> adopting a 
programme of Community action (1995-2000) - <
12> 
87.  As required by the Council, the Commission presented a report in November 1994 on 
the implementation of the 1993  action plan of the "Europe against AIDS"  programme 
1991-1993,<
13> as  well  as  a  report  on  the  execution  of the  "Europe  against  Cancer 
programme" in 1993<
14>  and a Communication on blood safety and self-sufficiency in the 
European Community<•s>. 
Moreover, the Commission's Action Programme on transport for people with reduced 
mobility<•
6> includes  a  medium-term  measure  for  the  enlarged  scope  of regulations 
banning/reducing  smoking  in  all  areas  of transport  (including  as  a  workplace)  in 
accordance with Council Resolution No. 89/C 189/01 of 18.7.1989 on banning smoking 
in places open to the public. 
2.15.3.  Solidarity 
88.  a)  Measures· to help the disabled 
(7S) 
(76) 
(77) 
(78) 
(79) 
(80) 
(81) 
(82) 
(83) 
(84) 
(85) 
(86) 
A  Council  Decision  of 25  February  1993  established  a  third  Community  action 
programme  to  promote  equal  opportunities  and  the  integration  of disabled  people, 
HELlOS II, from 1 January 1993 to 31 December 1996. The programme emphasises the 
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32 development  of exchange  and  information  activities,  and  the  cooperation  of non-
governmental organisations. 
89.  The Commission has also introduced a framework  initiative· on  "Employment"  which 
aims to contribute to the development of human resources, improve the workings of the 
labour market and  promote  social  solidarity  in  the European  Union.  There are three 
strands within the initiative, one of which, HORIZON, gives priority to improving the 
employment prospects of disabled people. 
90.  b)  Measures to help older people 
Several measures relating to the health of older people were funded under the European 
Year  of  Older  People  and  Solidarity  Between  Generations  (1993).  In  1994  the 
Commission  financed  the  Community's  "Healthy  Ageing"  operation  organised  by 
Eurolink Age. 
2.15.4.  Human riKhts and fundameptal freedoms 
91.  • Ethical aspects of bjotechnoloiY 
In November 1991, in the context of the policy to promote the competitiveness of the 
biotechnology industries (Communication SEC (91)  629 final,  White Paper on Growth, 
Competitiveness and  Employment), the Commission set up a group of  advisers on ethical 
implications in  biotechnology.  The  mandate  of this  independent group  is  to  give  its 
opinion to the Commission on the ethical questions arising in the various applications 
of biotechnology, i.e. health, agriculture, agrifood industry and the environment. In the 
medical  field,  biotechnology  offers  considerable  hopes  in  respect  of treatment  or 
diagnosis of genetic or acquired diseases.  New methods of treatment, which are often 
only  at the experimental  stage, involve risks and raise questions,  particularly in  terms. 
of ethics. The group of  advisers devotes special attention to such matters. In March 1993 
it  adopted  an  opinion  on  products  derived from  blood  or  human  plasma,  and  in 
December 1994 it delivered an opinion to the Commission on the ethical implications 
of gene therapy. 
2.15.5. Information apd culture 
92.  In  the  context of the EUROBAROMETER surveys  carried  out  for  the  Commission, 
special  surveys were  designed  to  reveal  Europeans'  attitudes,  opinions  and  levels  of 
knowledge concerning drugs,  cancer and AIDS. 
93.  In cooperation with the Council of Europe, the Commission has this year been working 
on two information campaigns where sport and health have been important elements. 
On the basis of the code of ethics in  sport drawn up by  the Council of Europe, a fair-
play campaign was established in  1993.  The code  of ethics underlines,  among  other 
things,  the  need  to  combat  drugs,  doping,  the  use  of alcohol  and  violence  and  to 
emphasise sport's role in  fostering social  relations and  well-being.  It also stresses the 
responsibility on sportsmen and women,  and on those in their immediate circle (clubs, 
coaches, parents).  The campaign's target groups are athletes and especially youngsters. 
33 T  -shirts,  stickers  and  posters  have  been  distributed  through  sport  organisations,  the 
Commission Offices, at different sport events, sports conferences, etc. throughout 1994. 
94.  Europack- information on doping : the second  information campaign in  cooperation 
with  the  Council  of Europe  is  an  educational  product,  which  has  the  objective  of 
supplying national and/or international (sports) organisations responsible for health care, 
or more specifically, for education on anti-doping, with materials on education in this 
area. 
ill.  HEALTH PROTECTION ASPECTS 
IN EXTERNAL RELATIONS 
3.1. Relations with third countries 
95.  In the relations between the European Community and third countries, health protection 
is included in both bilateral and regional programmes. 
96. 
(87) 
For  example,  drug  demand  reduction  is  a  key  element  of  the  Commission's 
multidisciplinary international drug programmes. These programmes encompass : 
- Measures covering primary and secondary prevention,  epidemiology and  training in 
priority countries and  regions such  as  the  Mediterranean Basin,  the Middle East and 
Central and Eastern Europe. 
- In the framework of  North/South cooperation on Drugs, part of the 10 MECU budget 
in  1994  is  devoted  to  prevention  and  health  aspects:  a joint Commission/UNESCO 
activity  is currently  establishing a world-wide  network of NGOs active  in the field, 
including those active in intra-Community programmes; 
- In  the PHARE Regional  Programme on  Drugs covering  11  PHARE countries (12 
MECU  for  two  years},  a  significant  part  is  devoted  to  health  prevention  aspects, 
including education and training; links have been established between the actions under 
this  programme  and  the  ones  carried  out within  the  Community,  such  as  the  1994 
European Drug Prevention Week. 
Moreover,  clauses  on  the  fight  against  drugs  are  included  m  the  agreements  the 
Community makes with third countries. 
The fight against drugs also makes use of the new opportunities offered by the Common 
Foreign and Security Policy. 
More generally,  a  number of health  projects  in  both  Central  and  Eastern  European 
Countries  (CEEC)  and  in  the  New  Independent  States  (NIS)  are  covered  by  the 
PHARE<•'> and T  ACIS programmes. 
Phare Health: Progress and strategy paper (1994) 
34 PHARE  act1V1t1es  within  the  health  sector  are  concerned  with  the  reforms  and 
restructuring necessary in  the CEEC  to  render  their  respective  health  systems  viable 
within a market economy context, financially sustainable and socially acceptable. 
In the light of analysis of the CEEC's problems in the health  sector, key  reforms and 
restructuri~g needs covered under the PHARE programme are:  · 
reform of the financing system including budget programming and allocation, cost 
containment measures, payment of care-providers, health insurances issues,  etc.; 
reorganisation  of health  services,  in  particular  to  make  care  increasingly  less 
hospital and more community based, including privatisation issues; 
pharmaceutical policy (legislation, pricing policy, supply and distribution system); 
human  resources  management  while  meeting  the  training  and  retraining  needs 
arising from the new health-service environment; 
development of disease prevention and  health promotion activities with a special 
focus on areas where EC directives and practices have been developed (health and 
safety at work for instance) 
Excluding humanitarian aid, over ECU 100 million has been made available for health 
sector reform in the period 1990-1993 in ten Central and Eastern European Countries, 
Bulgaria, Hungary, Poland and Romania being the major beneficiaries. 
97.  In the framework of TACIS, one project has so far been established in Russia for 4.5 
MECU.  The TACIS  approach to  activities  in  the  health  sector is  similar  to that of 
PHARE. 
3.2.  General development cooperation 
Cooperation.  wjtb  ACP countries jn the health field  and on AIDS 
98.  EC-ACP cooperation in the health field under Lome IV includes a major retargeting of 
assistance and a significant increase in allocated funding. After focusing for a long time 
on  the  construction  of health  infrastructure  and  the  supply  of equipment  and  being 
implemented through specific projects, assistance in the health field now responds to a 
more long-term vision and a more global sectoral approach.  It is designed to facilitate 
the definition and implementation of essential measures to reform health care systems. 
99.  A mid-term assessment shows that in terms of commitments the total volume of aid has 
progressed very rapidly during the initial years of  the seventh EDF. It now exceeds ECU 
0.5 billion, representing more than twice the sum undet the sixth EDF. On the basis of 
the data currently available, it may be estimated that cooperation in the health field will 
absorb more than 7% of resources under the seventh EDF. The resources released under 
the  "structUral  adjustment facility"  accourtt  for  half this totaL  In  tJm· way  it  will  be 
possible to maintain or even increase the public resources allocated to the health sector, 
particularJy those earmarke? for nelping to fund operation of health services. Assistance 
is  also being made availabl,e  to help  reform budget proct=dures  and  structures  with a 
view to improving  coherlll,~ between budgets and health policies. 
35 I 00.  The number and  size of projects and  programmes have also increased significantly in 
recent  years.  Half of the  resources  allocated  are  earmarked  for  the  primary  aqd 
secondary  sectors,  reflecting  the  emphasis  placed  on  reinforcing  basic  services.  A 
considerable effort is also being made to help countries improve their medicinal product 
supply systems, and make pharmaceutical products more accessible to their populations. 
The strengthening of institutional capacities and training also represent very important 
aspects of cooperation. 
10 I.  Since 1987 assistance has been given to the fight against the HIV and  AIDS epidemic, 
focusing on support for regional  and  national  prevention strategies,  particularly  those 
designed to improve services concerned with combating sexually transmissible diseases, 
promote information and awareness campaigns specifically aimed at risk  groups,  and 
improve blood transfusion safety. 
As far as IllY/AIDS is concerned, the EC's total financial contribution over the period 
1987-1994 amounted to around ECU 87 million and was allocated to measures covering 
85  developing countries in Africa, Asia and Latin America. 
102.  Substantial  assistance  has also  been given  to  health  measures  under  "rehabilitation" 
programmes in countries experiencing serious crises. Finally, a significant proportion of 
co-financing granted to European NGOs has been earmarked for improving the health 
of the populations of developing countries. 
103.  At the end of 1993  and in the course of 1994 the Commission launched and supported 
a  process  geared  to  improving  coordination  between  European partners.  This  was 
achieved  mainly  through  meetings  of European  experts  and  the  development  of 
exchanges of information. 
One of the most important results of this process was the adoption, on 6 May  1994, by 
the Council of: 
a  Resolution  (COM(94)  77)  setting  out the general  framework  for  a  policy  of 
cooperation  for  the  Community  and  Member  States  in  the  field  of health  and 
emphasising the need for parallel  action to create an environment which is  more 
conducive to health and facilitate the reform of health care systems; 
a  Resolution  referring  more  specifically  to  lllV/AIDS  and  setting  out  policy 
principles and action priorities, with the emphasis on the need to: 
•  control the spreading of the epidemic, 
•  strengthen  the  health  sector  to  enable  it  to  face  up  to  the  additional  burden 
represented by IDV/AIDS,  . 
•  give more consideration to the economic and social consequences of the epidemic 
•  improve scientific knowledge in this field. 
3.3.  Humanitarian  aid 
104.  ECHO, the European Community Humanitarian Office, which has been operational since 
April ·1992,  was  set  up  against the  background  of an  explosion  in  the  demand  for 
humanitarian  aid  throughout  the  world  as  a  result  of the  major  crises  which  the 
international  community  has  had  to  face  up  to  in  recent  years.  Aiming  to  achieve 
36 efficiency and speed up reactions, ECHO prepares, implements, finances,  monitors and 
assesses operations and decisions relating to humanitarian aid,  including food  aid and 
help for refugees and displaced persons. 
105.  ECHO's operational activities in the health field include integration of health protection 
aspects into  humanitarian  aid operations  through  several  types of action  to  help  the 
victims of disasters: 
Medicinal products:  the  most  important aspect  of the  Office's  work  relating  to 
health. 
Vaccination campaigns. 
Supply of  medical equipment (minor surgery, general  surgery,  operating theatres, 
etc.), as well as specific equipment for the disabled (protheses) or health equipment 
(hygiene kits), etc. 
Food:  health  aspects  are  systematically  taken  into  account  in  deciding  the 
composition of  food aid, both in terms of assessment of  the nutritional needs of the 
food aid recipients and in controlling food distribution, in accordance with standards 
laid down by WHO. 
Re-education:  functional  rehabilitation for the disaMed,  as  well  as  psychological 
support (e.g. Bosnian rape victims). 
Environment: infrastructure operations to improve the general level of  health and 
hygiene (wells, health units), health and hygiene measures including the supply of 
detergents, water treatment or even the supply of quality-controlled seeds. 
Very often, part of the funds allocated to these activities is earmarked for the training 
of  local medical staff. 
106.  Although operational activities represent the main aspect of ECHO's work, prevention 
activities  have  become  significantly  more  important  over  the  past  year.  "Disaster 
preparedness" measures. have been developed primarily for dealing with natural disasters.' 
At the World Conference on the prevention of natural disasters held in  Yokohama in 
May  1994,  which took stock of the outcome of the International Decade for Natural 
Disaster Reduction, ECHO launched its programme of action on disaster preparedness 
and prevention.  This includes, in the health field,  training for  disaster victims (public 
health, health education, etc.). 
107.  The "training"  aspect is also  involved in  measures to boost the  skills  of the staff r.'!f 
ECHO partners.  A university diploma in humanitarian aid has been cre(tted 'by ECHO 
in  conjunction with DG XXII and  hat been developed  in  several  universities  in  the 
Member States. This multidisci)h'inary diploma, a European conception of  the "Erasmus" 
type,  covers  five  m_e.)·ur  disciplines  relevant  to  the  humanitarian  field,  particularly 
rriedicine-epiliuruology. Teaching started in September 1994. 
3.4.  International organisations and conferences 
108.  On  21  June  1994,  in  the context of its  cooperation with  the Council of Europe,  the 
Community  deposited  the  instruments  of  ratification  for  the  Convention  on  the 
Elaboration  of a  European  Pharmacopoeia.  The  Commission  departments  regularly 
. foUow the work of  the Council of  Europe and particularly of its committees, which draw 
up conventions which the Community may  also sign. 
37 The Commission subsidised and organised in collaboration with the Pompidou Group, 
Athens, March 1994, an international conference on the management of drug addicts in 
prison.  The participants were professionals  working in  the  drug field,  administrators 
form  the Ministries  of Health  and  Justice  and  researchers  to  allow  exchanges  from 
different approaches. Conclusions setting guidelines on the management of drug addicts 
in prison  ~ave been adopted by the majority of participants.  · 
109.  The  Commission  subsidised  and  participated  actively  in  the  Xth  International 
Conference on AIDS, Yokohama, 7-12 August 1994. Press information notices as well 
as a Blue Book: "The  World with HIVIAJDS:  the  European Community response-
1994"  summarising  the  AIDS-related  activities  of the  Commission,  were  widely 
distributed.  A  European  Community  stand  presenting  activities  in  the  fields  of 
development, public health and research was visited by  several thousand participants. 
Moreover,  a European Commission Pre-Conference was  organised focusing  on both 
AIDS public health issues in Europe and aid development programmes. 
IV.  HEALTH PROTECTION ASPECTS OF COOPERATION IN 
THE FIELD OF JUSTICE AND HOME AFFAIRS 
Drugs 
110.  When the Treaty on European Union came into force on 1 November 1993, it opened 
up the possibility of integrated action by the Union in the fight against drugs, using its 
competences in public health (Article 129), in the Common Foreign and Security Policy 
(Title V), and in Justice and Home Affairs (Title VI).  In June 1994 the Commission 
was therefore able to present a draft multiannual Global Action Plan for the Union for 
the period 1995-1999 <
11>,  which further emphasises prevention measures in the context 
of an  integral  and  coordinated  response  to the  drugs  phenomenon,  together  with  a 
specific Community  programme to  fight  against drug  dependence based  on  its  new 
competence for public health (sec point 2.15.2 of this report).  So far the Global Action Plan 
has received a warm welcome from  the Member States, the European Parliament and 
ECOSOC.  The Essen European Council asked the Council  to ensure that discussions 
on the Global Action Plan were completed in time for the conclusions to be put before 
the Cannes European Council in June 1995. 
111.  The European Monitoring Centre for Drugs and Drug Addiction, the EMCDDA, was 
set up by Council Regulation (EEC) No 302/93<
19> and came into force on 30 October 
1993 following the decision by the European Council on the seats of the decentralised 
agencies.  It  has  a  mandate to  provide  the  Community  and  its  Member  States  with 
objective,  reliable  and  comparable  information  at  European  level  on  drugs  and  the 
consequences of drug addiction. 
(II) 
(19) 
The Centre will collect and analyse currently available data on the global drugs problem 
and  in particular data relating to reducing demand for drugs.  It will  seek to improve 
COM(94) 234 final 
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38 data  comparison  methods  through  the  Union  and  will  cooperate  actively  with  the 
Pompidou  Group  of the  Council  of Europe,  UNDCP  and  WHO  in  the  field  of 
information on  drugs. 
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V.  CONCLUSIONS  II 
Through the introduction of explicit provisions on health (Articles 3(o) and 129) in the 
EC Treat}}, the important role that health protection requirements play in Community 
policies has been recognised. 
This report on  health protection requirements  in Community  policies,  the first to be 
produced  by  the Commission  pursuant to Articles  3(o)  and  129  of the  E.C.  Treaty 
concerning health protection and  public health,  presents a survey of the way  health-
related isspes have been dealt with in existing Community policies. 
The  many  and  varied  measures  and  policies  that  are  relevant  to  health  and  the 
interactions between them have made it difficult to provide an overview that is at once 
reasonably comprehensive, fully coherent, clearly focused and not of  inordinate length. 
In this, the first such report the ideal  balance between these aims may not have been 
struck.  Improvements will therefore be sought in the preparation of future reports. 
This report illustrates that the provisions on health protection are already applied 
in many Community policies. It gives an overview of  the interface of  health with other 
policies and in  particular of the impact of Community measures on the health of the 
European citizen. Moreover, it demonstrates that the action of striving to improve the 
health of the citizens of the European Union in itself constitutes an  important added 
value in implementing the objectives of the European Union. 
This report deals not only with health protection, but also with all  matters which can 
have  a  significant  impact  on  public  health.  For  example,  the  modernisation  and 
increased efficiency of  infrastructures for transport, energy and environment will greatly 
benefit the health of citizens and improve the quality of  their lives. Many items covered 
under the 4th R  TO Framework Programme will also contribute to health protection, in 
particular the part of the new Biomedicine and Health<
24> programme concerning public 
health  research.  Similarly,  the  new Community  education  and  training  programmes 
SOCRA  TES<
90> and  LEONARDQ<
91> as  well  as  the  third  phase  of the  "Youth  for 
Europe" programme<
92
> will create better opportunities for the citizens of  the Community 
to take decisions about their own behaviour and health. 
It responds to the Treaty obligation and  demands from  the Council, the European 
Parliament  and  the  Economic  Social  Committee  and  will  help  to  improve  the 
transparency and coherence of Community policies, and inter-sectoral coordination on 
health protection related issues. 
Other  Community  policies  may  need  to  be  complemented  by  public  health 
measures.  Notably,  in  the agriculture sector  more consideration  should  be given to 
enhancing  intersectoral  cooperation  in  relation  to  the  development  of promotion 
campaigns aiming to improve nutritional balance and  putting emphasis on  increasing 
OJ L 87 of20.04.1995, p.  10 
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40 the consumption of those foods which are beneficial to health, such as fish and fruit and 
vegetables.  In  the context of action on  social  and  economic development,  and  in  the 
fight  against unemployment,  consideration  should  be  given  to  creating  more  health 
sector jobs to address new health needs.  However any  such action  must be balanced 
against the need to control health care costs.  But the issues of controlling health care 
costs and safeguarding social protection principles also have to be addressed. 
5.  Public health policies  need  to  be- complementary to other policies.  The  health 
protection requirement, as a component of  Community policy, should be applied in such 
a  way  as  not  to  conflict with the basic cornerstones  of the Union's  policy.  In  any 
Community action  health interests have to be carefully balanced with other interests 
such as economic and social factors. Excessive measures aimed at health protection in 
the field of consumer protection and agriculture can, for example, have adverse effects 
on  employment and  the  economic  situation  and  thus  ultimately  produce  a  negative 
impact on the health of the workers of the sectors involved. 
In  order to  achieve  balanced  and  coherent  policies  in  relation  to  health  protection 
measures  in  areas  such  as  industry,  agriculture  and  consumer  protection,  the 
Commission will  seek closer cooperation with the research,  health,  social  and  other 
sectors involved. 
Article 129 gives the Community a clear mandate for promoting research in the field 
of  disease  causation  and  transmission.  In  the  field  of  drugs,  for  example,  the 
Commission will ensure coherence between the drug dependence programme, the work 
carried out by the EMCDDA and the Community's specific programmes under the 4th 
Framework Programme for R:search, particularly regarding research on biomedicine and 
health,  including  research  on  causes  and  toxic  effects of drug  dependence  but  also 
taking  into  consideration  results  from  the  new  Targeted  Socio-economic  Research 
programme, in particular those arising from "Research into social integration and social 
exclusion in Europe", as well as from the COST Social Sciences research collaboration 
action A6. 
6.  This report, by outlining the interrelationships between different policy areas, aims to 
reinforce  the  intersectoral  coordination  of health  protection  aspects  in  Community 
policy. Such coordination can increase synergy and avoid duplication of effort and thus 
improve the efficiency and effectiveness of the operations undertaken to the benefit of 
all  Community citizens. 
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